HAMILTON BEACH BRANDS HOLDING CO, 10-K filed on 2/25/2026
Annual Report
v3.25.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2025
Feb. 20, 2026
Jun. 30, 2025
Entity Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-38214    
Entity Registrant Name HAMILTON BEACH BRANDS HOLDING COMPANY    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 31-1236686    
Entity Address, Address Line One 4421 Waterfront Dr.    
Entity Address, City or Town Glen Allen    
Entity Address, State or Province VA    
Entity Address, Postal Zip Code 23060    
City Area Code (804)    
Local Phone Number 273-9777    
Title of 12(b) Security Class A Common Stock, Par Value $0.01 Per Share    
Trading Symbol HBB    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction Flag false    
Entity Shell Company false    
Entity Public Float     $ 140,761,042
Documents Incorporated by Reference
Portions of the Company’s Proxy Statement for its 2026 annual meeting of stockholders are incorporated herein by reference in Part III of this Form 10-K.
    
Entity Central Index Key 0001709164    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false    
Class A Common Stock      
Entity Information [Line Items]      
Entity Common Stock, Shares Outstanding   9,839,337  
Class B Common Stock      
Entity Information [Line Items]      
Entity Common Stock, Shares Outstanding   3,585,996  
v3.25.4
Audit Information
 12 Months Ended
Dec. 31, 2025
Audit Information [Abstract]  
Auditor Firm ID 42
Auditor Name Ernst & Young LLP
Auditor Location Richmond, Virginia
v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenue $ 606,852 $ 654,693 $ 625,625
Cost of sales 450,699 484,486 481,949
Gross profit 156,153 170,207 143,676
Selling, general and administrative expenses 119,263 126,703 108,395
Amortization of intangible assets 311 302 200
Operating profit 36,579 43,202 35,081
Interest expense, net 703 613 3,000
Pension termination expense 0 7,611 0
Other expense (income), net 235 1,602 385
Income before income taxes 35,641 33,376 31,696
Income tax expense (benefit) 9,186 2,617 6,454
Net income $ 26,455 $ 30,759 $ 25,242
Basic earnings per share (in dollars per share) $ 1.95 $ 2.20 $ 1.80
Diluted earnings per share (in dollars per share) $ 1.95 $ 2.20 $ 1.80
Basic weighted average shares outstanding (in shares) 13,552 13,950 14,036
Diluted weighted average shares outstanding (in shares) 13,571 13,963 14,060
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net income $ 26,455 $ 30,759 $ 25,242
Other comprehensive income, net of tax:      
Foreign currency translation adjustment 3,914 (5,867) 1,859
Gain (loss) on long-term intra-entity foreign currency transactions 0 0 653
Cash flow hedging activity (1,548) 2,371 (3,365)
Reclassification of hedging activities into earnings (928) (1,223) 1,631
Pension plan adjustment 205 999 103
Reclassification related to pension termination activity into earnings 48 5,668 0
Reclassification of pension adjustments into earnings 106 142 370
Total other comprehensive income, net of tax 1,797 2,090 1,251
Comprehensive income $ 28,252 $ 32,849 $ 26,493
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 47,313 $ 45,644
Trade receivables, net 110,535 117,068
Inventory 133,833 124,904
Prepaid expenses and other current assets 13,052 16,103
Total current assets 304,733 303,719
Property, plant and equipment, net 30,253 34,401
Right-of-use lease assets 34,614 36,049
Goodwill 7,099 7,099
Other intangible assets, net 2,093 2,101
Deferred tax assets 3,607 6,693
Deferred costs 2,925 16,156
Other non-current assets 12,300 8,849
Total assets 397,624 415,067
Current liabilities    
Accounts payable 86,376 104,161
Accrued compensation 13,956 18,792
Accrued product returns 7,875 7,876
Lease liabilities 5,497 5,193
Other current liabilities 9,529 18,098
Total current liabilities 123,233 154,120
Revolving credit agreements 50,000 50,000
Lease liabilities, non-current 36,416 39,008
Other long-term liabilities 5,130 6,036
Total liabilities 214,779 249,164
Stockholders’ equity    
Preferred stock, par value $0.01 per share 0 0
Capital in excess of par value 80,795 76,668
Treasury stock (35,213) (26,202)
Retained earnings 143,888 123,863
Accumulated other comprehensive loss (6,780) (8,577)
Total stockholders’ equity 182,845 165,903
Total liabilities and stockholders’ equity 397,624 415,067
Class A Common Stock    
Stockholders’ equity    
Common stock 119 115
Class B Common Stock    
Stockholders’ equity    
Common stock $ 36 $ 36
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical)
shares in Thousands
Dec. 31, 2025
$ / shares
shares
Dec. 31, 2024
$ / shares
shares
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares, issued (in shares) | shares 11,870 11,476
Class B Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares, issued (in shares) | shares 3,587 3,603
Common stock, convertible conversion ratio 1 1
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities      
Net income $ 26,455 $ 30,759 $ 25,242
Adjustments to reconcile net income to net cash provided by (used for) operating activities:      
Depreciation and amortization 5,887 4,801 4,362
Deferred income taxes 3,753 (7,269) (906)
Stock compensation expense 4,131 6,270 5,394
Pension termination expense 0 7,611 0
Other 99 6,354 (358)
Net changes in operating assets and liabilities:      
Trade receivables 9,303 13,840 (18,768)
Inventory (6,666) (4,103) 30,761
Other assets 9,598 713 10,856
Accounts payable (18,110) 4,747 37,493
Other liabilities (20,637) 1,692 (5,440)
Net cash provided by (used for) operating activities 13,813 65,415 88,636
Investing activities      
Expenditures for property, plant and equipment (2,777) (3,193) (3,419)
Acquisition of business, net of cash acquired 0 (7,412) 0
Issuance of secured loan 0 (600) (1,605)
Repayment of secured loan 0 2,205 0
Purchase of U.S. Treasury bill 0 (4,884) 0
Proceeds from maturity of U.S. Treasury bill 5,000 0 0
Other (291) 0 (150)
Net cash provided by (used for) investing activities 1,932 (13,884) (5,174)
Financing activities      
Net additions (reductions) to revolving credit agreements 0 0 (60,916)
Purchase of treasury stock (8,987) (14,106) (3,074)
Cash dividends paid (6,430) (6,294) (6,082)
Financing fees paid 0 (548) 0
Net cash provided by (used for) financing activities (15,417) (20,948) (70,072)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 461 (438) 1,084
Cash, cash equivalents and restricted cash      
Increase (decrease) for the year 789 30,145 14,474
Balance at the beginning of the year 46,524 16,379 1,905
Balance at the end of the year $ 47,313 $ 46,524 $ 16,379
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reconciliation of cash, cash equivalents and restricted cash      
Cash and cash equivalents $ 47,313 $ 45,644 $ 15,370
Restricted cash included in prepaid expenses and other current assets 0 880 72
Restricted cash included in other non-current assets 0 0 937
Total cash, cash equivalents and restricted cash $ 47,313 $ 46,524 $ 16,379
v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Capital in Excess of Par Value
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022 $ 124,534 $ 107 $ 38 $ 65,008 $ (8,939) $ 80,238 $ (11,918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 25,242         25,242  
Issuance of common stock, net of conversions 2 5 (2) (1)      
Purchase of treasury stock (3,074)       (3,074)    
Stock compensation expense 5,394     5,394      
Cash dividends (6,082)         (6,082)  
Other comprehensive income (loss) (750)           (750)
Reclassification adjustment to net income 2,001           2,001
Ending balance at Dec. 31, 2023 147,267 112 36 70,401 (12,013) 99,398 (10,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 30,759         30,759  
Issuance of common stock, net of conversions 0 3   (3)      
Purchase of treasury stock (14,189)       (14,189)    
Stock compensation expense 6,270     6,270      
Cash dividends (6,294)         (6,294)  
Other comprehensive income (loss) (2,497)           (2,497)
Reclassification adjustment to net income 4,587           4,587
Ending balance at Dec. 31, 2024 165,903 115 36 76,668 (26,202) 123,863 (8,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 26,455         26,455  
Issuance of common stock, net of conversions 0 4   (4)      
Purchase of treasury stock (9,011)       (9,011)    
Stock compensation expense 4,131     4,131      
Cash dividends (6,430)         (6,430)  
Other comprehensive income (loss) 2,571           2,571
Reclassification adjustment to net income (774)           (774)
Ending balance at Dec. 31, 2025 $ 182,845 $ 119 $ 36 $ 80,795 $ (35,213) $ 143,888 $ (6,780)
v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]      
Cash dividends (in dollars per share) $ 0.475 $ 0.455 $ 0.435
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Nature of Operations and Summary of Significant Accounting Policies Nature of Operations and Summary of Significant Accounting Policies
Nature of Operations

Throughout this Annual Report on Form 10-K and the notes to consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”).

We are a leading designer, marketer and distributor of a wide range of brand name small electric household and specialty housewares appliances, and commercial products for restaurants, fast food chains, bars and hotels, and are a provider of connected devices and software for healthcare management.

Basis of Presentation and Principles of Consolidation

The accompanying consolidated financial statements include the financial statements of the Company and have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). Intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and disclosure of contingent assets and liabilities (if any). Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include cash in banks and highly liquid investments with original maturities of three months or less.

U.S. Treasury Bills

During the third quarter of 2024, the Company invested $9.8 million of excess cash on hand into two U.S. Treasury Bills with original maturities of three and six months. U.S. Treasury Bills with an original maturity of 3 months or less are included within cash and cash equivalents on the Consolidated Balance Sheets and those greater than 3 months but less than one year are included within prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company classified these U.S. Treasury Bills as held-to-maturity as it intended to hold these securities until maturity. Held-to-maturity debt securities are recorded at amortized cost. Discounts from and premiums to par value on held-to-maturity debt securities are accreted/amortized into interest income over the life of the respective security using the effective interest method. The Company evaluates for other than temporary impairment on an ongoing basis. No impairment has been recognized for investments in debt securities for any period presented. As of December 31, 2025 and 2024, the amortized cost and net carrying value of the security recognized in prepaid expenses and other current assets was $0 and $5.0 million, respectively. There were no U.S. Treasury Bills recognized within cash and cash equivalents on the Consolidated Balance Sheets as of December 31, 2025 or 2024.

Trade Receivables

Allowances for credit losses are maintained against trade receivables for estimated losses resulting from the inability of customers to make required payments. These allowances are based on both recent trends of certain customers estimated to be a greater credit risk as well as general trends of the entire customer pool. Accounts are written off against the allowance when it becomes evident collection will not occur.
The Company maintains significant trade receivables balances with several large retail customers. As of December 31, 2025 and 2024, receivables from the Company’s five largest customers represented 65% and 68%, respectively, of HBB’s net trade receivables. The Company’s significant credit concentration is uncollateralized; however, historically, minimal credit losses have been incurred.

Accounts payable - Supplier Finance Program

The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $65.0 million in payment obligations. There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows. As of December 31, 2025 and 2024, the Company has $29.9 million and $56.9 million, respectively, in outstanding payment obligations that are presented in Accounts payable on the Consolidated Balance Sheets. Of these totals, the third-party financial institution has made payments to participating suppliers to settle $21.8 million and $48.2 million, respectively, of our outstanding payment obligations.

A rollforward of the Company’s outstanding payment obligations confirmed as valid under our supplier finance program for the period shown were as follows:


 2025
Confirmed obligations outstanding as of January 1$56,940 
Invoices confirmed during the year170,263 
Confirmed invoices paid during the year(197,327)
Confirmed obligations outstanding as of December 31$29,876 

Transfer of Financial Assets

The Company has entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. Under the terms of the agreement, the Company receives cash proceeds and retains no rights or interest and has no obligations with respect to the sold receivables. These transactions, which are accounted for as sold receivables, result in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $145.0 million and $149.7 million of trade receivables during 2025 and 2024, respectively. The losses incurred on sold receivables in the Consolidated Statements of Operations for the years ended December 31, 2025, 2024 and 2023 were not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities.

Inventory

Inventory is stated at the lower of cost or net realizable value with cost determined under the first-in, first-out (“FIFO”) method. Adjustments to the carrying value are recorded for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions.
Property, Plant and Equipment

Property, plant and equipment are measured at cost less accumulated depreciation, amortization and accumulated impairment losses. Depreciation and amortization are recorded generally using the straight-line method over the estimated useful lives of the assets. Estimated lives for buildings are up to 40 years, and for machinery, equipment and furniture and fixtures range from three to seven years. Leasehold improvements are depreciated over the shorter of the estimated useful life or the term of the lease. The units-of-production method is used to amortize certain tooling for sourced products. Costs incurred to develop software for internal use are capitalized and amortized over the estimated useful life of the software. If the useful life of property, plant and equipment is reassessed during any period, the Company recognizes accelerated depreciation expense in accordance with the reduced expected holding period of the asset. Gains or losses from the sale of assets are included in selling, general and administrative expenses. Repairs and maintenance are charged to expense as incurred. Interest is capitalized for qualifying long-term capital asset projects as a part of the historical cost of acquiring the asset.

The Company evaluates long-lived assets for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount exceeds the fair value of the asset. Fair value is estimated at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

Goodwill and Intangible Assets

Goodwill represents the excess of the purchase price of acquisitions over the estimated fair value of the net assets acquired. Goodwill is not amortized but evaluated at least annually for impairment. The Company conducts its annual test for impairment as of October 1 of each year and it may be conducted more frequently if changes in circumstances or the occurrence of events indicates that a potential impairment exists. The Company may elect to perform a qualitative assessment that considers economic, industry, and company-specific factors for all or selected reporting units. If, after completing this assessment, it is determined that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value, the Company would proceed to a quantitative test. The Company may also elect to perform a quantitative test instead of a qualitative assessment for any or all of the reporting units. For the quantitative test, the Company determines the estimated fair value through the use of both a market-based approach and a discounted cash flow valuation model incorporating discount rates commensurate with the risks involved for each reporting unit. The assumptions used in the discounted cash flow valuation model for impairment testing includes discount rates, revenue growth rates and operating profit margin rates, and terminal growth rates. If the estimated fair value of the reporting unit is less than the current carrying value, impairment of goodwill of the reporting unit is recognized.

The impairment assessment is performed at the reporting unit level. The Company’s reporting units have been identified at the operating segment level.

Intangible assets with finite lives are amortized over their estimated useful lives, which represent the period over which the asset is expected to contribute directly or indirectly to future cash flows. Intangible assets with finite lives are reviewed for impairment whenever events and circumstances indicate the carrying value of such assets may not be recoverable and exceed their fair value. If an impairment loss exists, the carrying amount of the intangible asset is adjusted to a new cost basis. The new cost basis is amortized over the remaining useful life of the asset.

No impairment has been recognized for identifiable intangible assets or goodwill for any period presented.
Environmental Liabilities

The Company and environmental consultants are investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses the Company has acquired. Liabilities for environmental matters are recorded in the period when it is determined to be probable and reasonably estimable that the Company will incur costs. When only a range of amounts is reasonably estimable and no amount within the range is more probable than another, the Company records the low end of the range. Environmental liabilities are recorded on an undiscounted basis and associated expense is recorded in selling, general and administrative expenses. When recovery of a portion of an environmental liability is probable, such amounts are recognized as a reduction to selling, general and administrative expenses and included in prepaid expenses and other current assets (current portion) and other non-current assets until settled.

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenue. At contract inception, the Company assesses the goods and services promised in its contracts with customers and identifies a performance obligation for each promised good or service that is distinct. The Company has elected to account for shipping and handling activities performed after a customer obtains control of the goods as activities to fulfill the promise to transfer the goods, and therefore these activities are not assessed as a separate service to customers. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company determines whether price concessions offered to its customers are a reduction of the transaction price and revenue or are advertising expense, depending on whether the Company receives a distinct good or service from its customers and, if so, whether the Company can reasonably estimate the fair value of that distinct good or service. The Company evaluated such agreements with its customers and determined they should be accounted for as variable consideration.

To estimate variable consideration, the Company applies both the expected value method and most likely amount method based on the form of variable consideration, according to which method would provide the better prediction. The expected value method involves a probability weighted determination of the expected amount, whereas the most likely amount method identifies the single most likely outcome in a range of possible amounts.

Product Development Costs

Expenses associated with the development of new products and changes to existing products are charged to expense as incurred. These costs, included in selling, general and administrative expenses, amounted to $13.2 million, $13.7 million and $12.4 million in 2025, 2024 and 2023, respectively.

Foreign Currency

Assets and liabilities of foreign operations are translated into U.S. dollars at the fiscal year-end exchange rate. Revenue and expenses of all foreign operations are translated using average monthly exchange rates prevailing during the year. The related translation adjustments, including translation on long-term intra-entity foreign currency transactions, are recorded as a separate component of stockholders’ equity.

Financial Instruments

Financial instruments held by the Company include cash and cash equivalents, U.S. Treasury Bills, trade receivables, accounts payable, revolving credit agreements, interest rate swap agreements and forward foreign currency exchange contracts. The Company does not hold or issue financial instruments or derivative financial instruments for trading purposes. Interest rate swap agreements and forward foreign currency exchange contracts held by the Company have been designated as hedges of forecasted cash flows. The Company holds these derivative contracts with high-quality financial institutions and limits the amount of credit exposure to any one institution. The Company does not currently hold any nonderivative instruments designated as hedges or any derivatives designated as fair value hedges.
The Company uses forward foreign currency exchange contracts to partially reduce risks related to transactions denominated in foreign currencies. The Company offsets fair value amounts related to foreign currency exchange contracts executed with the same counterparty. These contracts hedge firm commitments and forecasted transactions relating to cash flows associated with sales and purchases denominated in currencies other than the subsidiaries’ functional currencies. Changes in the fair value of forward foreign currency exchange contracts that are effective as hedges are recorded in accumulated other comprehensive income (loss) (“AOCI”). Deferred gains or losses are reclassified from AOCI to the Consolidated Statements of Operations in the same period as the gains or losses from the underlying transactions are recorded and are generally recognized in cost of sales.

The Company uses interest rate swap agreements to partially reduce risks related to floating rate financing agreements that are subject to changes in the market rate of interest. Terms of the interest rate swap agreements require the Company to receive a variable interest rate and pay a fixed interest rate. The Company’s interest rate swap agreements and its variable rate financings are predominately based upon SOFR (Secured Overnight Financing Rate). For cash flow hedges, the Company formally assesses, both at inception and on a quarterly basis thereafter, whether the designated derivative instrument is highly effective in offsetting changes in cash flows of the hedged item. Changes in the fair value of interest rate swap agreements that are effective as hedges are recorded in AOCI. Deferred gains or losses are reclassified from AOCI to the Consolidated Statements of Operations in the same period as the gains or losses from the underlying transactions are recorded and are generally recognized in interest expense, net. The Company discontinues hedge accounting prospectively when the derivative is not highly effective as a hedge, the underlying hedged transaction is no longer probable or the hedging instrument expires, is sold, terminated or exercised.

The Company periodically enters into foreign currency exchange contracts that do not meet the criteria for hedge accounting. These derivatives are used to reduce the Company’s exposure to foreign currency risk related to forecasted purchase or sales transactions or forecasted intercompany cash payments or settlements. Gains and losses on these derivatives are included in other expense, net.

Cash flows from hedging activities are reported in the Consolidated Statements of Cash Flows in the same classification as the hedged item, generally as a component of cash flows from operations.

Fair Value Measurements

The Company defines the fair value measurement of its financial assets and liabilities as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

A fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value.

Described below are the three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.
Level 2 - Observable prices that are based on inputs not quoted on active markets but corroborated by market data.
Level 3 - Unobservable inputs are used when little or no market data is available.

The hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement.
Stock Compensation

Pursuant to the Executive Long-Term Equity Incentive Plan (the “Executive Plan”) established in September 2017, and amended and restated in March 2024, the Company grants shares of Class A Common, subject to transfer restrictions, as a means of retaining and rewarding selected employees for long-term performance. Shares awarded under the Executive Plan are fully vested and entitle the stockholder to all rights of common stock ownership except that shares may not be assigned, pledged or otherwise transferred during the restriction period. In general, the restriction period ends after three, five or ten years from the award date or at the earliest of (1) three years after the participant’s retirement date, or (2) the participant’s death or permanent disability. The Company issued 306,039, 241,947 and 169,227 shares of Class A Common in the years ended December 31, 2025, 2024 and 2023, respectively. After the issuance of these shares, there were 705,355 shares of Class A Common available for issuance under this plan. Stock compensation expense related to the Executive Plan was $2.8 million, $5.1 million and $4.2 million for the years ended December 31, 2025, 2024 and 2023, respectively, and was based on the fair value of Class A Common on the grant date.

The Company also has a stock compensation plan for non-employee directors of the Company under which a portion of the annual retainer for each non-employee director is paid in transfer-restricted shares of Class A Common. For the years ended December 31, 2025 and 2024, $112,000 and $110,000, respectively, ($150,000 for the Chairman) of the non-employee director’s annual retainer of $179,000 and $175,000, respectively, ($250,000 for the Chairman) was paid in transfer-restricted shares of Class A Common. Shares awarded under the plan are fully vested and entitle the stockholder to all rights of common stock ownership except that shares may not be assigned, pledged or otherwise transferred during the restriction period. In general, the transfer restriction period ends at the earliest of (1) ten years after the Quarter Date with respect to which such Required Shares were issued or transferred, (2) the date of the director’s death or date the director terminates service as a director due to permanent disability, (3) five years (or earlier with the approval of the Board) after the director’s date of retirement from the Board, or (4) the date the director has both retired from the Board and has reached age 70. Pursuant to this plan, the Company issued 71,999, 60,235 and 100,238 shares in the years ended December 31, 2025, 2024 and 2023, respectively. In addition to the mandatory retainer fee received in transfer-restricted stock, directors may elect to receive shares of Class A Common in lieu of cash for up to 100% of the balance of their annual retainer, committee retainer and any committee chairman’s fees. These voluntary shares are not subject to any restrictions. There were no shares issued under voluntary elections in 2025, 2024 and 2023. After the issuance of these shares, there were 361,174 shares of Class A Common available for issuance under this plan. Stock compensation expense related to these awards was $1.3 million, $1.2 million and $1.2 million for the years ended December 31, 2025, 2024 and 2023, respectively. Stock compensation expense represents fair value based on the market price of the shares of Class A Common on the grant date.

Leases

Lessee

In accordance with Accounting Standards Codification 842, the Company determines whether an arrangement is a lease at inception, considering whether the contract conveys a right to control the use of the identified asset for a period of time in exchange for consideration. Leases are classified as operating or finance leases at the commencement date of the lease. Operating leases are included in Right-of-use lease assets, Lease liabilities and Lease liabilities, non-current on the Consolidated Balance Sheets.

Right-of-use lease assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. Lease liabilities are classified between current and non-current liabilities based on their contractual payment terms. The right-of-use lease asset includes prepaid rent and reflects the unamortized balance of lease incentives. The Company’s leases may include renewal options, and the renewal option is included in the lease term if it is concluded that it is reasonably certain that we will exercise that option. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company has operating leases for real estate, equipment and production specific tooling assets used by our third-party suppliers. The Company has finance leases for certain equipment. The Company has elected not to record short-term leases with initial terms of twelve months or less in its Consolidated Balance Sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Lease expense for finance leases is recognized on a straight-line basis over the lease term unless a purchase option is exercised to transfer title at the end of the lease term in which case the expense is amortized over the useful life of the asset. Variable lease payments that do not depend on an index or a rate, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, insurance and property taxes, are excluded from the measurement of the lease liability, unless subject to fixed minimum requirements, and are recognized as variable lease cost when the obligation for that payment is incurred. The Company combines lease and non-lease components as a single component for all asset classes. Lease expense is classified as cost of sales or selling, general and administrative expenses in its Consolidated Statements of Operations based on the use of the leased item.

As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company’s estimated incremental borrowing rate reflects a secured rate based on recent debt issuances, its estimated credit rating, lease term, as well as publicly available data for instruments with similar characteristics.

Lessor

The Company is the lessor of connected devices to specialty pharmacy networks and pharmaceutical companies. The devices are leased on a month-to-month basis and therefore are short-term leases. These leases are classified as operating leases. There are no options to purchase the device at the end of the term. Revenue is recognized on a straight-line basis based on quantity of connected devices in service during the month. The Company combines lease and non-lease components as a single component for all asset classes.

Treasury Stock

The Company records the aggregate purchase price of treasury stock at cost and includes treasury stock as a reduction to stockholders’ equity.

Income Taxes

Tax law requires certain items to be included in the tax return at different times than the items are reflected in the financial statements. Some of these differences are permanent, such as expenses that are not deductible for tax purposes, and some differences are temporary, reversing over time, such as depreciation expense. These temporary differences create deferred tax assets and liabilities using currently enacted tax rates. The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year, and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the financial statements or tax returns. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date. The Company is required to estimate the timing of the recognition of deferred tax assets and liabilities, make assumptions about the future deductibility of deferred tax assets and assess deferred tax liabilities based on enacted law and tax rates for the appropriate tax jurisdictions to determine the amount of such deferred tax assets and liabilities. Changes in the calculated deferred tax assets and liabilities may occur in certain circumstances, including statutory income tax rate changes, statutory tax law changes or changes in the Company’s structure or tax status.

The Company’s tax assets, liabilities and tax expense are supported by historical earnings and losses and the Company’s best estimates and assumptions of future earnings by jurisdiction. The Company assesses whether a valuation allowance should be established against the Company’s deferred tax assets based on consideration of all available evidence, both positive and negative, using a more likely than not standard. This assessment considers, among other matters, scheduled reversals of deferred tax liabilities, projected future taxable income, tax-planning strategies and results of recent operations. The assumptions about future taxable income require significant judgment and are consistent with the plans and estimates the Company is using to manage the underlying businesses. When the Company determines, based on all available evidence, that it is more likely than not that deferred tax assets will not be realized, a valuation allowance is established.
Accounting Standards Adopted

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The Company adopted ASU 2023-09 prospectively for the annual period beginning January 1, 2025, and it affects only our disclosures and does not impact our results of operations or financial condition.

Recently Issued Accounting Standards

In November 2024, the FASB issued ASU 2024-03, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40),” which requires additional information to be disclosed about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.

In July 2025, the FASB issued ASU 2025-05, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which provides a practical expedient in estimating credit losses for current accounts receivables and current contract assets arising from transactions accounted for under Topic 606 that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. The amendments are effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, “Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40):Targeted Improvements to the Accounting for Internal-Use Software,” which modernizes previously written guidance around internal-use software costs by eliminating accounting consideration of software project development stages and provides for cost capitalization when management has authorized and committed funding to the project and that the project is considered ‘probable’ of completion and the software used to perform the function as intended, along with prescriptive disclosure requirements associated with internal-use software costs to be consistent with Subtopic 360-10, “Property, Plant and Equipment” regardless of how those costs are presented in the financial statements. The amendments are effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The amendment may be applied either retrospectively or prospectively or on a modified prospective basis prescribed by the ASU. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.
v3.25.4
Property, Plant and Equipment, Net
 12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment, Net [Abstract]  
Property, Plant and Equipment, Net Property, Plant and Equipment, Net
Property, plant and equipment, net includes the following:
 December 31
 20252024
Land$226 $226 
Furniture and fixtures10,146 9,946 
Building and improvements9,583 9,511 
Machinery and equipment33,523 33,021 
Internal-use capitalized software16,696 15,867 
Construction in progress1,696 2,180 
Property, plant and equipment, at cost71,870 70,751 
Less allowances for depreciation and amortization41,617 36,350 
 $30,253 $34,401 

Depreciation expense from property, plant and equipment, net for the years ended December 31, 2025, 2024 and 2023 was $5.6 million, $4.5 million, and $4.2 million, respectively.
v3.25.4
Goodwill and Intangible Assets
 12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Intangible assets other than goodwill, which are subject to amortization, consist of the following:

 Gross Carrying
Amount		Accumulated
Amortization		Net
Balance
Balance as of December 31, 2025
   
Trademarks$3,100 $(2,208)$892 
Developed technology1,424 (223)1,201 
$4,524 $(2,431)$2,093 
Balance as of December 31, 2024
   
Trademarks$3,100 $(2,008)$1,092 
Developed technology1,111 (102)1,009 
$4,211 $(2,110)$2,101 

Amortization expense for intangible assets was $0.3 million, $0.3 million and $0.2 million for the years ended December 31, 2025, 2024 and 2023, respectively.

Expected annual amortization expense of intangible assets for the next five years is $0.4 million. The weighted average amortization period for intangible assets is approximately 6.1 years.

The goodwill balance was $7.1 million as of both December 31, 2025 and 2024. The acquisition of HealthBeacon resulted in the addition of $0.8 million in goodwill during the year ended December 31, 2024 which is attributable to the Health segment. The remaining goodwill balance is attributable to the Home and Commercial Products segment.

For the annual goodwill impairment assessment in the current year, the Company elected to forego the qualitative assessment and instead performed a quantitative test for its Home and Commercial Products reporting unit. The estimated fair value for the Home and Commercial Products reporting unit significantly exceeded its carrying amount, and therefore no impairment of goodwill was recognized. For the Health reporting unit, the Company used a qualitative assessment and determined that it was more-likely-than-not that the goodwill was not impaired and a quantitative test for impairment was not required.
v3.25.4
Current and Long-Term Financing
 12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Current and Long-Term Financing Current and Long-Term Financing
Financing arrangements exist at the subsidiary level. Hamilton Beach Brands Holding Company has not guaranteed any borrowings of its subsidiaries.

The following table summarizes HBB’s available and outstanding borrowings:
 December 31
 20252024
Total outstanding borrowings:  
Revolving credit agreements$50,000 $50,000 
Total outstanding borrowings$50,000 $50,000 
Total available borrowings, net of limitations, under revolving credit agreements$123,783 $107,257 
  
Unused available borrowings$73,783 $57,257 
  
Weighted average stated interest rate on total borrowings5.94 %5.20 %
Weighted average effective interest rate on total borrowings (including interest rate swap agreements)3.30 %2.50 %
Including swap settlements, interest paid on total debt was $0.9 million, $0.5 million and $3.0 million during 2025, 2024 and 2023, respectively. Interest capitalized was not material in 2025, 2024 and 2023.

The HBB Facility the company has is a $125 million senior secured floating-rate revolving credit facility that expires with repayment due on December 13, 2029. The HBB Facility also has an optional $25.0 million term loan. The obligations under the HBB Facility are secured by all of HBB’s U.S. assets. The HBB Facility also requires HBB to achieve a minimum fixed charge coverage ratio in certain circumstances, as defined in the HBB Facility. As of December 31, 2025, HBB was in compliance with all financial covenants in the HBB Facility.

The maximum availability under the HBB Facility is governed by a borrowing base derived from advance rates against eligible trade receivables and inventory of HBB. As of December 31, 2025, interest on outstanding loans under the HBB Facility accrues at a per annum rate equal to, at HBB’s option, either Term Secured Overnight Financing Rate (SOFR) (as defined in the HBB Facility) plus 1.65% or the Base Rate (as defined in the HBB Facility) plus 0.00%. As of December 31, 2025, the HBB Facility requires a fee of 0.20% per annum on the unused commitment thereunder.

To reduce the exposure to changes in the market rate of interest, HBB has entered into interest rate swap agreements for a portion of the HBB Facility. Terms of the interest rate swap agreements require HBB to receive a variable interest rate and pay a fixed interest rate.
HBB does not expect to make voluntary repayments within the next twelve months under the HBB Facility as the rate of return to invest excess cash exceeds the average interest rate of the HBB Facility. A material decrease in interest rates could cause HBB to re-evaluate.
v3.25.4
Fair Value Disclosure
 12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Disclosure Fair Value Disclosure
Recurring Fair Value Measurements

The Company measures its derivatives at fair value using significant observable inputs, which is Level 2 as defined in the fair value hierarchy. The Company uses a present value technique that incorporates the SOFR swap curve, foreign currency spot rates and foreign currency forward rates to value its derivatives, including its interest rate swap agreements and foreign currency exchange contracts. The Company also incorporates the effect of HBB and counterparty credit risk into the valuation.

Other Fair Value Measurement Disclosures

The carrying amounts of cash and cash equivalents, trade receivables and accounts payable approximate fair value due to the short-term maturities of these instruments. The fair value of the HBB Facility, including book overdrafts, which approximate book value, were determined using current rates offered for similar obligations taking into account HBB’s credit risk, which is Level 2 as defined in the fair value hierarchy.

There were no transfers into or out of Levels 1, 2 or 3 during the years ended December 31, 2025 and 2024.
v3.25.4
Derivative Financial Instruments
 12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Foreign Currency Derivatives

HBB held forward foreign currency exchange contracts with total notional amounts of $1.7 million and $18.8 million as of December 31, 2025 and 2024, respectively, denominated primarily in Canadian dollars and Mexican pesos. The fair value of these contracts approximated a payable of $0.1 million as of December 31, 2025 and a receivable of $0.8 million as of December 31, 2024.

Forward foreign currency exchange contracts that qualify for hedge accounting are used to hedge transactions expected to occur within the next twelve months. The mark-to-market effect of forward foreign currency exchange contracts that are considered effective as hedges has been included in AOCI.
Interest Rate Derivatives

HBB has interest rate swaps that hedge interest payments on its one-month SOFR borrowings. All swaps have been designated as cash flow hedges.

The following table summarizes the notional amounts, related rates and remaining terms of interest rate swap agreements for HBB as of December 31, in millions:
 Notional Amount Average Fixed RateRemaining Term at
 2025202420252024December 31, 2025
Interest rate swaps$50.0 $50.0 1.6 %1.6 %Extending to January 2029
The fair value of HBB’s interest rate swap agreements was a receivable of $2.0 million as of December 31, 2025 and a receivable of $4.0 million as of December 31, 2024. The mark-to-market effect of interest rate swap agreements that are considered effective as hedges has been included in AOCI. The interest rate swap agreements held by HBB on December 31, 2025 are expected to continue to be effective as hedges.

The following table summarizes the fair value of derivative instruments as of December 31, as recorded in the Consolidated Balance Sheets:
 Asset DerivativesLiability Derivatives
 Balance sheet location20252024Balance sheet location20252024
Interest rate swap agreements      
CurrentPrepaid expenses and other current assets$831 $1,144 Other current liabilities$— $— 
Long-termOther non-current assets1,199 2,808 Other long-term liabilities— — 
Foreign currency exchange contracts      
CurrentPrepaid expenses and other current assets— 789 Other current liabilities126 — 
Total derivatives $2,030 $4,741  $126 $— 
v3.25.4
Leasing Arrangements
 12 Months Ended
Dec. 31, 2025
Lessee Disclosure [Abstract]  
Leasing Arrangements Leasing Arrangements
Lessee

At commencement of the Company’s leases, right-of-use assets and corresponding liabilities are recognized based on the present value of future lease payments over the lease term. Some of the Company’s leases, primarily those for real estate assets, may contain both lease and non-lease components. The Company has elected to combine and account for lease and non-lease components as a single lease component. Leases with an initial term of 12 months or less are not recorded in the Consolidated Balance Sheets and lease expense for these leases are recognized on a straight-line basis over the lease term. The Company’s leases have remaining lease terms of one month to 12 years, some of which include options to extend the leases for up to 5 years. The renewal option is included in the lease term if it is concluded that it is reasonably certain that the Company will exercise that option.

The assets associated with the Company’s leases primarily consist of real estate and equipment. Real estate leases are comprised of warehouses, global headquarters and sales offices. Equipment leases include office and warehouse equipment as well as Company specific tooling used by third-party suppliers in the production process. Payments under these lease arrangements may be fixed or variable.
December 31
20252024
Operating lease cost$7,172 $8,112 
Finance lease cost
Amortization of leased assets74 72 
Interest on lease liabilities22 28 
Finance lease cost96 100 
Variable lease cost (1)
318,309 368,948 
Short term lease cost (2)
46 52 
Total lease cost$325,623 $377,212 

(1) Amounts primarily reflect product purchases that are associated with production related tooling.
(2) Leases with an initial term of 12 months or less

The Company recognized a $0.7 million impairment charge in 2024 related to the consolidation of warehouses, which is included within cost of sales in the Consolidated Statements of Operations and relates to the Home and Commercial Products segment. The impairment was measured using a discounted cash flow based on the marketed rate of the warehouse and the time expected to identify a sub-lessor.

The following table presents supplemental cash flow and non-cash information related to leases:
December 31
20252024
Cash paid for amounts included in the measurement of lease liabilities – operating cash flows from leases$8,066 $8,799 
Right-of-use assets obtained in exchange for lease obligations of operating leases – non-cash activity$3,397 $2,624 
Right-of-use assets obtained in exchange for lease obligations of finance leases – non-cash activity$6 $73 

The following table reconciles the undiscounted future lease payments for operating and finance leases to the lease liabilities recorded in the Consolidated Balance Sheet as of December 31, 2025:
Undiscounted Future Lease Payments
2026$7,530 
20277,079 
20286,661 
20296,493 
20305,791 
Thereafter16,889 
Total lease payments50,443 
Less: impact of discounting8,530 
Present value of lease payments$41,913 
The following table summarizes the weighted-average lease term and discount rate.
December 31
20252024
Weighted average remaining lease term in years - operating leases7.38.3
Weighted average remaining lease term in years - finance leases2.63.6
Weighted average discount rate - operating leases (1)
5.2 %5.1 %
Weighted average discount rate - finance leases (1)
7.3 %7.3 %
(1) The discount rates used to present value the lease liabilities are based on estimates of the Company’s incremental borrowing rate.

As of December 31, 2025, the Company did not have any additional material operating or finance leases that had not yet commenced.

Lessor

The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies. The lease payments are assessed per unit on a monthly basis. The devices are leased on a month-to-month basis and therefore are short-term leases. These leases are classified as operating leases. There are no options to purchase the device at the end of the term. The devices are classified as property, plant and equipment, net on the Consolidated Balance Sheets. Total lease revenue was $5.7 million and $3.2 million for the years ended December 31, 2025 and 2024, respectively.
v3.25.4
Stockholders' Equity and Earnings Per Share
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders' Equity and Earnings Per Share Stockholders' Equity and Earnings Per Share
Capital Stock

The authorized capital stock of the Company consists of Class A Common, Class B Common and one series of Preferred stock. Voting, dividend, conversion and liquidation rights of the Preferred stock are established by the Board upon issuance of such Preferred stock.

The Company’s Class A Common is traded on the New York Stock Exchange under the ticker symbol “HBB.” Because of transfer restrictions on Class B Common, no trading market has developed, or is expected to develop, for Class B Common.

Subject to the rights of the holders of any series of preferred stock, each share of Class A Common will entitle the holder of the share to one vote on all matters submitted to stockholders, and each share of the Company’s Class B Common will entitle the holder of the share to ten votes on all such matters. Subject to the rights of the preferred stockholders, each share of Class A Common and Class B Common will be equal in respect of rights to dividends, except that in the case of dividends payable in stock, only Class A Common will be distributed with respect to Class A Common and only Class B Common will be distributed with respect to Class B Common. As the liquidation and dividend rights are identical, any distribution of earnings would be allocated to Class A and Class B stockholders on a proportionate basis, and accordingly the net income per share for each class of common stock is identical.
The following table sets forth the Company’s authorized capital stock information:
December 31
20252024
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 
Preferred stock outstanding— — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 
Class A Common issued(1)(2)
11,870 11,476 
Treasury Stock(3)
2,052 1,545 
Class B Common stock, par value $0.01 per share, convertible into Class A on a one-for-one basis
Class B Common authorized30,000 30,000 
Class B Common issued(1)
3,587 3,603 
(1)    Class B Common converted to Class A Common were 16 shares during 2025 and 13 shares during 2024.
(2)     The Company issued Class A Common of 378 during 2025 and 302 during 2024 related to the Company’s stock compensation plan.
(3)     On February 21, 2025 and March 5, 2024, a total of 39 and 30 mandatory cashless-exercise-award shares of Class A Common, respectively, were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan.

Stock Repurchases

In November 2025, the Company’s Board approved a stock repurchase program for the purchase of up to $25 million of the Company’s Class A Common outstanding starting January 1, 2026 and ending December 31, 2027. This program replaced the previous stock repurchase plan that started January 1, 2024 and ended December 31, 2025. During the years ended December 31, 2025, 2024 and 2023, the Company repurchased 467,804, 638,381 and 250,772 shares for an aggregate purchase price of $8.3 million, $13.5 million and $3.1 million, respectively.

Additionally, during the years ended December 31, 2025 and 2024, the Company withheld shares for tax payments due upon issuance of stock to employees under the Incentive Plan. During the years ended December 31, 2025 and 2024, the Company repurchased 39,121 and 30,404 shares, respectively, for an aggregate purchase price of $0.7 million and $0.6 million, respectively, pursuant to the Incentive Plan.

The total combined share repurchases from the stock repurchase program and the Incentive Plan during the years ended December 31, 2025 and 2024, was 506,925 and 668,785 shares, respectively, for an aggregate purchase price (excluding the 1% excise tax as a result of the Inflation Reduction Act of 2022) of $9.0 million and $14.1 million, respectively.
Accumulated Other Comprehensive Income (Loss)

The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown:
Foreign CurrencyDeferred Gain (Loss) on Cash Flow HedgingPension Plan AdjustmentTotal
Balance, January 1, 2023$(8,924)$4,158 $(7,152)$(11,918)
Other comprehensive income (loss)2,792 (4,529)141 (1,596)
Reclassification adjustment to net income (loss)— 2,231 474 2,705 
Tax effects(280)564 (142)142 
Balance, December 31, 2023$(6,412)$2,424 $(6,679)$(10,667)
Other comprehensive income (loss)(5,867)3,256 1,344 (1,267)
Reclassification adjustment to net income (loss)— (1,629)7,805 6,176 
Tax effects— (479)(2,340)(2,819)
Balance, December 31, 2024$(12,279)$3,572 $130 $(8,577)
Other comprehensive income (loss)3,914 (2,191)279 2,002 
Reclassification adjustment to net income (loss)— (1,204)170 (1,034)
Tax effects— 919 (90)829 
Balance, December 31, 2025$(8,365)$1,096 $489 $(6,780)

Earnings per share

The weighted average number of shares of Class A Common and Class B Common outstanding used to calculate basic and diluted earnings (loss) per share were as follows:
 202520242023
Basic weighted average shares outstanding13,552 13,950 14,036 
Dilutive effect of share-based compensation awards19 13 24 
Diluted weighted average shares outstanding13,571 13,963 14,060 
Basic and diluted earnings (loss) per share$1.95 $2.20 $1.80 
v3.25.4
Revenue
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services, which includes an estimate for variable consideration.

The Company’s warranty program to the consumer consists generally of an assurance-type limited warranty lasting for varying periods of up to ten years for electric appliances, with the majority of products having a warranty of one to three years. There is no guarantee to the consumer as the Company may repair or replace, in its discretion, products returned under warranty. Accordingly, the Company determined that no separate performance obligation exists.

Most of the Company’s products are not sold with a general right of return. Subject to certain terms and conditions, however, the Company will agree to accept a portion of products sold that, based on historical experience, are estimated to be returned for reasons such as product failure and excess inventory stocked by the customer. Product returns, customer programs and incentive offerings, including special pricing agreements, price competition, promotions and other volume-based incentives are accounted for as variable consideration.

A description of revenue sources and performance obligations for the Company are as follows:

Consumer and Commercial product revenue
Transactions with both consumer and commercial customers generally originate upon the receipt of a purchase order from a customer, which in some cases are governed by master sales agreements, specifying product(s) that the customer desires. Contracts for product revenue have an original duration of one year or less, and payment terms are generally standard and based on customer creditworthiness. Revenue from product sales is recognized at the point in time when control transfers to the customer, which is either when a product is shipped from a Company facility, or delivered to customers, depending on the shipping terms. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company evaluated such agreements with its customers and determined returns and price concessions should be accounted for as variable consideration.

Consumer product revenue consists of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. A majority of this revenue is in North America.

Commercial product revenue consists of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales is in the U.S. and the remaining is in markets across the globe.

License revenue
From time to time, the Company enters into exclusive and non-exclusive licensing agreements which grant the right to use certain of the Company’s intellectual property (“IP”) in connection with designing, manufacturing, distributing, advertising, promoting and selling the licensees’ products during the term of the agreement. The IP that is licensed generally consists of trademarks, trade names, patents, trade dress, logos and/or products (the “Licensed IP”). In exchange for granting the right to use the Licensed IP, the Company receives a royalty payment, which is a function of (1) the total net sales of products that use the Licensed IP and (2) the royalty percentage that is stated in the licensing agreement. The Company recognizes revenue at the later of when the subsequent sales occur or when the performance obligation is satisfied over time. Additionally, the Company enters into agreements which grant the right to use software for healthcare management. The Company receives a license payment which is recognized when the performance obligation is satisfied over time or as usage occurs based on the contract with the customer.

Lease revenue
The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies and is accounted for under Accounting Standards Codification 842, Leases as operating leases.
The following table sets forth the Company’s revenue on a disaggregated basis for the year ended:
Year Ended
December 31
 202520242023
Consumer products$532,373 $592,801 $568,006 
Commercial products59,898 51,755 52,327 
Licensing8,909 6,917 5,292 
Leasing5,672 3,220 — 
     Total revenues$606,852 $654,693 $625,625 

Walmart Inc. and its global subsidiaries accounted for approximately 29%, 29% and 27% of the Company’s revenue in 2025, 2024 and 2023, respectively. Amazon.com, Inc. and its subsidiaries accounted for approximately 19%, 24% and 24% of the Company’s revenue in 2025, 2024 and 2023 respectively. The Company’s five largest customers accounted for approximately 62%, 65% and 64% of its revenue in 2025, 2024 and 2023, respectively.
v3.25.4
Contingencies
 12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, environmental and other claims. Although it is difficult to predict the ultimate outcome of these proceedings and claims, the Company believes the ultimate disposition of these matters will not have a material adverse effect on the financial condition, results of operation or cash flows of the Company. Any costs that the Company estimates will be paid as a result of these claims are accrued when the liability is considered probable and the amount of such costs can be reasonably estimated. The Company does not accrue liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated or when the liability is believed to be only reasonably possible or remote. For contingencies where an unfavorable outcome is probable or reasonably possible and which are material, the Company discloses the nature of the contingency and, in some circumstances, an estimate of the possible loss.

Environmental matters

The Company is investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses it acquired. Based on the current stage of the investigation or remediation at each known site, the Company estimates the total investigation and remediation costs and the period of assessment and remediation activity required for each site. The estimate of future investigation and remediation costs is primarily based on variables associated with site clean-up, including, but not limited to, physical characteristics of the site, the nature and extent of the contamination and applicable regulatory programs and remediation standards.
As of December 31, 2025 and 2024, the Company had accrued undiscounted obligations of $2.9 million and $3.9 million respectively, for environmental investigation and remediation activities. The decrease in the amount accrued as of December 31, 2025 compared to December 31, 2024 is due to a change in the expected extent of investigation and remediation activities associated with some of the sites and remediation payments made during the year. The Company estimates that it is reasonably possible that it may incur additional expenses in the range of zero to $1.0 million related to the environmental investigation and remediation at these sites. Additionally, the Company has a $0.6 million asset associated with the reimbursement of costs associated with two sites.
v3.25.4
Income Taxes
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of income (loss) before income taxes and the income tax expense (benefit) for the years ended December 31 are as follows:
 202520242023
Income (loss) before income taxes  
Domestic$32,980 $33,403 $24,008 
Foreign2,661 (27)7,688 
$35,641 $33,376 $31,696 
Income tax expense (benefit)  
Current income tax expense (benefit):  
Federal$2,555 $8,457 $3,412 
State1,142 2,790 1,452 
Foreign1,736 (1,361)2,496 
Total current5,433 9,886 7,360 
Deferred income tax expense (benefit):  
Federal3,434 (4,573)910 
State703 (998)(9)
Foreign(384)(1,698)(1,807)
Total deferred3,753 (7,269)(906)
 $9,186 $2,617 $6,454 

Total cash paid for income taxes (net of refunds) by jurisdiction for the year ended December 31, 2025 is as follows:
 2025
 
U.S. Federal$6,890 
State$2,830 
Foreign: 
Canada$826 
Mexico2,612 
Other217 
Foreign Subtotal$3,655 
Total cash paid for income taxes (net of refunds)$13,375 

The Company made $5.8 million and $3.1 million federal income tax payments during 2024 and 2023, respectively, to the IRS. The Company made foreign and state income tax payments of $5.2 million and $3.2 million during 2024 and 2023, respectively. No income tax refunds were received in 2024. Income tax refunds totaled $0.1 million during 2023.
A reconciliation of the federal statutory and effective income tax rate for the year ended December 31, 2025 is as follows:
2025
 $%
Income (loss) before income taxes$35,641 
Statutory taxes at 21%
$7,485 21.0 %
State and local income taxes1,602 4.5 %
Foreign tax effects794 2.2 %
Effect of cross-border tax laws(702)(2.0)%
U.S. tax credits(962)(2.7)%
Valuation allowances166 0.5 %
Non-deductible expenses related to sec. 162(m)812 2.3 %
Unrecognized tax benefits(9)— %
Income tax provision$9,186 25.8 %
Effective rate25.77 %
State taxes in Virginia, California, Illinois, and Pennsylvania made up the majority (greater than 50 percent) of the tax effect in the "State and Local Income Tax" category.

A reconciliation of the federal statutory and effective income tax rate for the years ended December 31, 2024 and 2023 are as follows:

20242023
 $%$%
Income (loss) before income taxes$33,376 $31,696 
Statutory taxes at 21%
$7,009 21.0 %$6,656 21.0 %
State and local income taxes1,610 4.8 %1,224 3.9 %
Valuation allowances635 1.9 %13 0.1 %
Other non-deductible expenses1,196 3.6 %402 1.3 %
Credits(1,148)(3.4)%(860)(2.7)%
Effect of foreign operations (1)
(4,330)(13.1)%(946)(3.0)%
Unrecognized tax benefits(32)(0.1)%422 1.3 %
Accounting method change (2)
(2,278)(6.8)%— — %
Other, net(45)(0.1)%(457)(1.5)%
Income tax provision$2,617 7.8 %$6,454 20.4 %
Effective rate7.84 %20.36 %

(1) The 2024 period includes a tax benefit for deducting certain historical foreign operating losses.
(2) During the fourth quarter of 2024, the Company filed IRS form 3115 Application for Change in Accounting Method, for depreciation. The result of the filing was a benefit of $2.3 million.
A detailed summary of the total deferred tax assets and liabilities in the Company’s Consolidated Balance Sheets resulting from differences in the book and tax basis of assets and liabilities follows:
 December 31
 20252024
Deferred tax assets  
Tax carryforwards$7,126 $5,982 
Lease liabilities1,797 2,003 
Inventory3,014 802 
Accrued expenses and reserves3,670 2,963 
Other employee benefits527 259 
Depreciation and amortization— 3,646 
Other— 32 
Total deferred tax assets16,134 15,687 
Less: Valuation allowances(7,126)(5,982)
 9,008 9,705 
Deferred tax liabilities  
Accrued pension benefits2,754 3,373 
Depreciation and amortization2,636 — 
Other11 — 
Total deferred tax liabilities5,401 3,373 
Net deferred tax asset $3,607 $6,332 

As of December 31, 2025 and 2024, respectively, the Company maintained valuation allowances with respect to certain deferred tax assets relating primarily to operating losses in certain non-U.S. jurisdictions that the Company believes are not likely to be realized.

The following table summarizes the tax carryforwards and associated carryforward periods and related valuation allowances where the Company has determined that realization is uncertain:
 December 31, 2025
 Net deferred tax
asset		Valuation
allowance		Carryforwards
expire during:
Non-U.S. net operating loss$6,960 $6,960 2026 - Indefinite
U.S. capital loss$166 $166 2030
Total$7,126 $7,126 

 December 31, 2024
 Net deferred tax
asset		Valuation
allowance		Carryforwards
expire during:
Non-U.S. net operating loss$5,982 $5,982 2025 - Indefinite

Based upon the review of historical earnings and the relevant expiration of carryforwards, the Company believes the valuation allowances are appropriate and does not expect to release valuation allowances within the next twelve months that would have a significant effect on the Company’s financial position or results of operations.
The Company continues to conclude all material entities’ foreign earnings will be indefinitely reinvested in its foreign operations and will remain offshore in order to meet the capital and business needs outside of the U.S. As a result, the Company does not provide a deferred tax liability with respect to the cumulative unremitted earnings. It is not practicable to determine the deferred tax liability associated with these undistributed earnings due to the availability of foreign tax credits and the complexity of the rules governing the utilization of such credits under the new rules under the Tax Act. The Company recognizes any tax impacts of global intangible low-taxed income (GILTI) as period costs similar to other special deductions, and not as deferred taxes for basis differences.

The following is a reconciliation of the Company’s total gross unrecognized tax benefits, defined as the aggregate tax effect of differences between tax return positions and the benefits recognized in the financial statements for the years ended December 31, 2025, 2024 and 2023. Approximately $0.6 million, $0.6 million and $1.4 million of these gross amounts as of December 31, 2025, 2024 and 2023, respectively, relate to permanent items that, if recognized, would impact the effective income tax rate.
 202520242023
Balance as of January 1$618 $1,447 $256 
Additions (reductions) based on tax positions related to prior years(39)(769)769 
Additions (reductions) based on tax positions related to the current year— — 493 
Reductions for lapse of statute of limitations— (60)(71)
Reductions due to settlements with taxing authorities— — — 
Balance as of December 31$579 $618 $1,447 

The Company records interest and penalties on uncertain tax positions as a component of the income tax provision. The Company recognized no income or expense for the years ended December 31, 2025, 2024 and 2023. The total amount of interest and penalties accrued was $0.1 million as of December 31, 2025. There were no accruals for interest and penalties as of December 31, 2024 and 2023.

In general, the Company operates in taxing jurisdictions that provide a statute of limitations period ranging from three to five years for the taxing authorities to review the applicable tax filings. The Company is generally open for examination of foreign jurisdictions for the tax year 2018 and beyond. In addition, the Company has extended the U.S. federal statute of limitations for tax years 2017 through 2019 related to a specific issue. Other than the extension related to a specific issue, the Company does not have any material taxing jurisdictions in which the statute of limitations has been extended beyond the applicable time frame allowed by law.
v3.25.4
Retirement Benefit Plans
 12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Retirement Benefit Plans Retirement Benefit Plans
Defined Benefit Plans

The Company maintains one active defined benefit pension plan in Canada (the “Canada Pension Plan”) that provides benefits based on years of service and average compensation during certain periods. The Canada Pension Plan was frozen, effective December 31, 2008.

There is also one terminated defined benefit pension plan (the “U.S. Pension Plan”) that was frozen, effective December 31, 1996, for participation and benefit accrual purposes (except cash balance interest credits required by law). During 2022, the Board approved the termination of our U.S. Pension Plan with an effective date of September 30, 2022. The Company substantially completed the termination in 2024. The surplus assets as of December 31, 2024 were $13.4 million which were included within prepaid expenses and other current assets on the Consolidated Balance Sheets. During the first quarter of 2025, the Company transferred $13.4 million of surplus assets to a qualified replacement plan which will be used to fund qualifying employee retirement benefits in the future. During 2025, $4.3 million was used to fund employee retirement benefits. As of December 31, 2025, the Company had $3.7 million included in prepaid expenses and other current assets and $5.5 million included in other non-current assets on the Consolidated Balance Sheets, which is inclusive of accrued interest income.
The weighted-average assumptions used in accounting for the defined benefit plans were as follows for the years ended December 31:
 20242023
U.S. Pension Plan
 
Discount rate for pension benefit obligationn/a5.01 %
Discount rate for net periodic benefit (income) expensen/a5.34 %
Expected long-term rate of return on assets for net periodic pension (income) expensen/a4.00 %
 202520242023
Canada Pension Plan
Discount rate for pension benefit obligation4.67 %4.58 %4.63 %
Discount rate for net periodic benefit (income) expense4.58 %4.63 %5.15 %
Expected long-term rate of return on assets for net periodic pension (income) expense6.00 %6.00 %6.00 %

During 2024, the Company remeasured the U.S. Pension Plan since benefit obligations were settled through a combination of lump sum payments to eligible plan participants and the purchase of a group annuity contract, under which future benefit obligations were transferred to a third-party insurance company. The remeasurement resulted in pre-tax settlement charges of $7.6 million ($5.7 million post-tax) during the year ended December 31, 2024, which were released from Accumulated Other Comprehensive Income into earnings and are included within Pension termination expense on the Consolidated Statements of Operations.

The discount rate for net periodic benefit (income) expense used during the period January 1, 2024 to August 31, 2024 was 5.01%. Due to the U.S. Pension Plan termination, the discount rate used for the period September 1, 2024 to December 31, 2024 period was 0.00%. The expected long-term rate of return on assets used for the net periodic benefit (income) expense used during the period January 1, 2024 to August 31, 2024 was 3.00%. Due to the U.S. Pension Plan termination, the expected long-term rate of return on assets used for the net periodic benefit (income) expense for the period September 1, 2024 to December 31, 2024 period was 0.00%.

Set forth below is a detail of the net periodic pension (income) expense, included in other expense (income), net for the defined benefit plans for the years ended December 31:

 20242023
U.S. Pension Plan
Interest cost$379 $674 
Expected return on plan assets(521)(1,082)
Amortization of actuarial loss238 358 
Settlement loss7,611 — 
Net periodic pension (income) expense$7,707 $(50)

 202520242023
Canada Pension Plan
Interest cost$140 $147 $162 
Expected return on plan assets(271)(263)(258)
Amortization of actuarial loss (gain)108 (44)118 
Net periodic pension (income) expense$(23)$(160)$22 
Set forth below is the detail of other changes in plan assets and benefit obligations (pre-tax) recognized in other comprehensive loss (income) for the years ended December 31:

 20242023
U.S. Pension Plan
Current year actuarial loss (gain)$(998)$(33)
Settlement loss(7,611)— 
Amortization of actuarial loss(238)(358)
Total recognized in other comprehensive loss (income)$(8,847)$(391)

 202520242023
Canada Pension Plan
Current year actuarial loss (gain)$(279)$(346)$(108)
Amortization of actuarial (loss) gain(108)44 (118)
Total recognized in other comprehensive loss (income)$(387)$(302)$(226)
The following table sets forth the changes in the benefit obligation and the plan assets during the year and the funded status of the defined benefit plans as of December 31:
 20252024
 U.S. Pension PlanCanada Pension PlanU.S. Pension PlanCanada Pension Plan
Change in benefit obligation    
Projected benefit obligation at beginning of year$104 $3,077 $12,916 $3,401 
Interest cost— 140 379 147 
Annuity purchase refund— — 441 — 
Actuarial (gain) loss— (79)(1,610)18 
Benefits paid— (215)(1,030)(217)
Settlements(104)— (10,992)— 
Foreign currency exchange rate changes— 149 — (272)
Projected benefit obligation at end of year$— $3,072 $104 $3,077 
Accumulated benefit obligation at end of year$— $3,072 $104 $3,077 
Change in plan assets    
Fair value of plan assets at beginning of year$13,485 $4,505 $25,156 $4,654 
Actual return on plan assets— 466 (90)645 
Benefits paid— (215)(1,030)(217)
Annuity purchase refund— — 441 — 
Settlements— — (10,992)— 
Other— (172)— (189)
Foreign currency exchange rate changes— 226 — (388)
Transfer to qualified replacement plan (1)
(13,485)— — — 
Fair value of plan assets at end of year$— $4,810 $13,485 $4,505 
Funded status at end of year$— $1,738 $13,381 $1,428 
Amounts recognized in the balance sheets consist of:    
Deferred costs$— $1,738 $13,381 $1,428 
Components of accumulated other comprehensive loss consist of:  
Actuarial loss$— $592 $(62)$205 
Deferred taxes— (103)16 (29)
 $— $489 $(46)$176 
(1) During the first quarter of 2025, the Company transferred $13.4 million of U.S. Pension Plan surplus assets to a qualified replacement plan.

The Company recognizes as a component of benefit cost (income), as of the measurement date, any unrecognized actuarial net gains or losses that exceed 10% of the larger of the projected benefit obligations or the plan assets, defined as the “corridor.” Amounts outside the corridor are amortized over the average expected remaining lifetime of inactive participants for the pension plan. The gain (loss) amounts recognized in AOCI are not expected to be fully recognized until the plan is terminated or as settlements occur, which would trigger accelerated recognition.

The Company’s policy is to make contributions to fund its pension plan within the range allowed by applicable regulations. The Company does not expect to contribute to its Canada Pension Plan in 2026.

Pension benefit payments are made from assets of the pension plan.
Future pension benefit payments expected to be paid from assets of the Canada Pension Plan are:
 Canada Pension Plan
2026$241 
2027250 
2028247 
2029243 
2030236 
2031-20351,114 
 $2,331 

During 2024, the U.S. Pension Plan’s assets were moved into a money market fund due to the settlement of benefit obligations. During 2025, all of the surplus assets were transferred to a qualified replacement plan and there are no plan assets held as of December 31, 2025.

For the Canada Pension Plan, the expected long-term rate of return on defined benefit plan assets reflects the Company’s expectations of long-term rates of return on funds invested to provide for benefits included in the projected benefit obligations. In establishing the expected long-term rate of return assumption for plan assets, the Company considers the historical rates of return over a period of time that is consistent with the long-term nature of the underlying obligations of the plan as well as a forward-looking rate of return. The historical and forward-looking rates of return are used to determine the Company’s estimated rate of return assumption were based upon the rates of return earned or expected to be earned by investments in the equivalent benchmark market indices for each of the asset classes.

Expected returns for the Canada Pension Plan are based on fair market value for Canada Pension Plan assets.

The Canada Pension Plan maintains an investment policy that, among other things, establishes a portfolio asset allocation methodology with percentage allocation bands for individual asset classes. The investment policy provides that investments are reallocated between asset classes as balances exceed or fall below the appropriate allocation bands.

The following is the actual allocation percentage and target allocation percentage for the Canada Pension Plan assets as of December 31:
 
2025
Actual
Allocation
2024
Actual
Allocation
Target Allocation
Range
Canadian equity securities36.3 %32.7 %
25.0% - 35.0%
Non-Canadian equity securities41.0 %37.7 %
25.0% - 35.0%
Fixed income securities22.7 %29.6 %
30.0% - 50.0%
The fair value of each major category of the Company’s Canada Pension Plan assets are valued using observable inputs, either directly or indirectly, other than quoted market prices in active markets for identical assets. Following are the values as of December 31:
Canada Pension Plan
 20252024
U.S. equity securities$1,683 $1,458 
Non-U.S. equity securities2,033 1,714 
Fixed income securities1,094 1,333 
Total$4,810 $4,505 

As of December 31, 2024 the U.S. Plan had $13.0 million in a money market account.

Defined Contribution Plans

HBB maintains a defined contribution (401(k)) plan for substantially all U.S. employees and similar plans for Canadian and Irish employees. The Company’s U.S. plan provides employer safe harbor contributions based on plan provisions. All plans provide for a separate employer contribution. These plans permit additional profit-sharing contributions, determined annually, that are based on a formula that includes (1) the effect of actual operating profit results compared with targeted operating profit results and (2) the age and/or compensation of the participants. Total costs, including Company contributions, for these plans were $7.4 million in 2025, $6.1 million in 2024 and $5.0 million in 2023.
v3.25.4
Data by Geographic Region
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Data by Geographic Region Data by Geographic Region
Revenue and property, plant and equipment related to operations outside the U.S., based on customer and asset location, are as follows:
 U.S.OtherConsolidated
2025   
Revenue from unaffiliated customers $458,847 $148,005 $606,852 
Property, plant and equipment, net$23,560 $6,693 $30,253 
2024
Revenue from unaffiliated customers$511,248 $143,445 $654,693 
Property, plant and equipment, net$26,730 $7,671 $34,401 
2023
Revenue from unaffiliated customers $493,711 $131,914 $625,625 
Property, plant and equipment, net$23,068 $4,333 $27,401 
No single country outside of the U.S. comprised 10% or more of HBB’s revenue from unaffiliated customers. There are two countries outside of the U.S. that comprised 10% or more of HBB’s property, plant and equipment, net.
Segment Information
The Company’s operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health. These segments are organized principally by product and service category. The Company’s reportable segments are determined based on (1) financial information reviewed by the chief operating decision maker “CODM”, (2) operational structure of the Company which is designed and managed to share resources across the entire suite of products offered by the business, and (3) the basis upon which the CODM makes resource allocation decisions. The CODM for both segments is the Director, President and Chief Executive Officer of the Company. The CODM utilizes the segment operating profit (loss) to assess profitability and performance of actual results compared to forecasts.

The types of products and services from which each reportable segment derives its revenues are as follows:

Home and Commercial Products
Our Home and Commercial Products segment includes consumer product revenue, primarily concentrated in North America, consisting of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. Also included in this segment is commercial product revenue consisting of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales is in the U.S. and the remaining is in markets across the globe.

Health
Our Health segment is comprised of the HealthBeacon acquisition, as described in Note 15 - Acquisitions, plus selling and administrative expenses. The segment includes lease revenue in the U.S. and globally associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue associated with agreements which grant customers the right to use software for healthcare management.
The table below presents the revenues and significant expenses of the two reportable segments along with a reconciliation of segment profit (loss) to consolidated income (loss) before income taxes. Total assets by segment are not reported as the CODM does not regularly review asset information by segment.

Year Ended December 31
20252024
Home and Commercial ProductsHealthTotalHome and Commercial Products
Health (1)
Total
Revenue$599,503 $7,349 $606,852 $650,409 $4,284 $654,693 
Less:
Cost of sales448,913 1,786 450,699 483,444 1,042 484,486 
Selling, general and administrative expenses112,508 6,755 119,263 118,470 8,233 126,703 
Amortization of intangible assets200 111 311 200 102 302 
Segment profit (loss)$37,882 $(1,303)$36,579 $48,295 $(5,093)$43,202 
Reconciliation of segment profit (loss)
Interest expense, net703 613 
Pension termination expense— 7,611 
Other expense (income), net235 1,602 
Income before income taxes$35,641 $33,376 

(1) As noted in Note 15 - Acquisitions, the Company completed the acquisition of HealthBeacon on February 2, 2024. Therefore, the 2024 results for the Health segment represent activity from the date of acquisition through December 31, 2024.

During the years ended December 31, 2025 and 2024, the Home and Commercial Products segment had two customers that accounted for more than 10% of total consolidated revenue. These two customers had $178.3 million and $117.7 million of revenue, respectively during the year ended December 31, 2025 and $189.3 million and $154.1 million, respectively during the year ended December 31, 2024.

During the years ended December 31, 2025 and 2024, the Health segment had no customers that accounted for more than 10% of total consolidated revenue.
During the year ended December 31, 2023, the Company had one operating and one reportable segment, therefore, all required financial segment information for that year can be found in the consolidated financial statements.
v3.25.4
Segment Information
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Information Data by Geographic Region
Revenue and property, plant and equipment related to operations outside the U.S., based on customer and asset location, are as follows:
 U.S.OtherConsolidated
2025   
Revenue from unaffiliated customers $458,847 $148,005 $606,852 
Property, plant and equipment, net$23,560 $6,693 $30,253 
2024
Revenue from unaffiliated customers$511,248 $143,445 $654,693 
Property, plant and equipment, net$26,730 $7,671 $34,401 
2023
Revenue from unaffiliated customers $493,711 $131,914 $625,625 
Property, plant and equipment, net$23,068 $4,333 $27,401 
No single country outside of the U.S. comprised 10% or more of HBB’s revenue from unaffiliated customers. There are two countries outside of the U.S. that comprised 10% or more of HBB’s property, plant and equipment, net.
Segment Information
The Company’s operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health. These segments are organized principally by product and service category. The Company’s reportable segments are determined based on (1) financial information reviewed by the chief operating decision maker “CODM”, (2) operational structure of the Company which is designed and managed to share resources across the entire suite of products offered by the business, and (3) the basis upon which the CODM makes resource allocation decisions. The CODM for both segments is the Director, President and Chief Executive Officer of the Company. The CODM utilizes the segment operating profit (loss) to assess profitability and performance of actual results compared to forecasts.

The types of products and services from which each reportable segment derives its revenues are as follows:

Home and Commercial Products
Our Home and Commercial Products segment includes consumer product revenue, primarily concentrated in North America, consisting of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. Also included in this segment is commercial product revenue consisting of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales is in the U.S. and the remaining is in markets across the globe.

Health
Our Health segment is comprised of the HealthBeacon acquisition, as described in Note 15 - Acquisitions, plus selling and administrative expenses. The segment includes lease revenue in the U.S. and globally associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue associated with agreements which grant customers the right to use software for healthcare management.
The table below presents the revenues and significant expenses of the two reportable segments along with a reconciliation of segment profit (loss) to consolidated income (loss) before income taxes. Total assets by segment are not reported as the CODM does not regularly review asset information by segment.

Year Ended December 31
20252024
Home and Commercial ProductsHealthTotalHome and Commercial Products
Health (1)
Total
Revenue$599,503 $7,349 $606,852 $650,409 $4,284 $654,693 
Less:
Cost of sales448,913 1,786 450,699 483,444 1,042 484,486 
Selling, general and administrative expenses112,508 6,755 119,263 118,470 8,233 126,703 
Amortization of intangible assets200 111 311 200 102 302 
Segment profit (loss)$37,882 $(1,303)$36,579 $48,295 $(5,093)$43,202 
Reconciliation of segment profit (loss)
Interest expense, net703 613 
Pension termination expense— 7,611 
Other expense (income), net235 1,602 
Income before income taxes$35,641 $33,376 

(1) As noted in Note 15 - Acquisitions, the Company completed the acquisition of HealthBeacon on February 2, 2024. Therefore, the 2024 results for the Health segment represent activity from the date of acquisition through December 31, 2024.

During the years ended December 31, 2025 and 2024, the Home and Commercial Products segment had two customers that accounted for more than 10% of total consolidated revenue. These two customers had $178.3 million and $117.7 million of revenue, respectively during the year ended December 31, 2025 and $189.3 million and $154.1 million, respectively during the year ended December 31, 2024.

During the years ended December 31, 2025 and 2024, the Health segment had no customers that accounted for more than 10% of total consolidated revenue.
During the year ended December 31, 2023, the Company had one operating and one reportable segment, therefore, all required financial segment information for that year can be found in the consolidated financial statements.
v3.25.4
Acquisitions
 12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions Acquisitions
On February 2, 2024, we completed the acquisition of HealthBeacon Limited (“HealthBeacon”), a medical technology firm and strategic partner of the Company, for €6.9 million (approximately $7.5 million). The transaction was funded with cash on hand.

The acquisition of HealthBeacon was accounted for as a business combination using the acquisition method of accounting. The results of operations for HealthBeacon are included in the accompanying Consolidated Statements of Operations for the year ended December 31, 2025 and in the comparable period from the acquisition date until December 31, 2024. Pro forma financial information has not been presented, as revenue and expenses related to the acquisition do not have a material impact on the Company’s consolidated financial statements.
The following table sets forth HealthBeacon’s revenue and operating profit (loss) for the years ended December 31:

 2025 2024
Revenue$7,349 $4,284 
Operating profit (loss)$(710)$(4,277)

The purchase price allocation for HealthBeacon was final as of December 31, 2024.

There were no transaction costs during the year ended December 31, 2025. During the year ended December 31, 2024, we incurred transaction costs of approximately $1.3 million which are included in selling, general and administrative expenses on the Consolidated Statements of Operations.

The following table presents the final value of assets acquired and liabilities assumed:
Fair Values as of
February 2, 2024
Cash and cash equivalents$147 
Current assets1,452 
Property, plant and equipment, net6,634 
Goodwill847 
Other intangible assets, net1,111 
Total assets acquired10,191 
Liabilities, current2,016 
Liabilities, non-current616 
Total liabilities acquired2,632 
Purchase Price$7,559 
v3.25.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
HAMILTON BEACH BRANDS HOLDING COMPANY
YEAR ENDED DECEMBER 31, 2025, 2024 AND 2023
  Additions  
DescriptionBalance at Beginning of PeriodCharged to
Costs and
Expenses		Charged to
Other Accounts
— Describe		Deductions
— Describe		Balance at
End of
Period (B)
(In thousands)
2025      
Reserves deducted from asset accounts:      
Allowance for credit losses$2,521 $184 $— $(1,022)(A)$1,683 
Deferred tax valuation allowances $5,982 $338 — $806 (C)$7,126 
2024
Reserves deducted from asset accounts:      
Allowance for credit losses$1,036 $1,485 $— $— (A)$2,521 
Deferred tax valuation allowances $2,780 $686 $5,367 (D)$(2,851)(C), (E)$5,982 
2023
Reserves deducted from asset accounts:
Allowance for credit losses$957 $79 $— $— (A)$1,036 
Deferred tax valuation allowances $2,153 $6 $— $(621)(C)$2,780 

(A)Write-offs, net of recoveries and foreign exchange rate adjustments.
(B)Balances which are not required to be presented and those which are immaterial have been omitted.
(C)Foreign exchange rate adjustments.
(D)Opening balance sheet addition for the acquisition of HealthBeacon.
(E)The Company determined that the utilization of the assets associated with a portion of this valuation allowance are remote and have subsequently been written off.
v3.25.4
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Insider Trading Policies and Procedures
 12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
The Company is subject to various cybersecurity risks that could impact our systems and our ability to operate. We have developed processes to assess, identify and manage our risks related to cybersecurity threats which are incorporated into the Company’s overall risk management process. On an ongoing basis we utilize threat prevention systems to monitor, block and protect our information technology systems which are monitored continuously by trained security personnel. Our process to prevent cybersecurity incidents involves layered security architecture designed to protect our networks, end-user devices, servers, and cloud solutions. On a regular basis, we conduct phishing email simulations and provide training resources to our employees. We have an Incident Response Plan to outline our process to manage cybersecurity threats and incidents. We utilize industry recognized security and compliance experts for regular security assessments. In order to oversee and identify risks from cybersecurity threats associated with our use of third-party service providers, we review their compliance against internationally recognized standards. However, this does not mean that the Company, or our third-party service providers, will meet, or maintain, any particular technical standard, specification, or requirement in the future, but rather we use these standards as a guide to help us identify, assess and manage cybersecurity risks and threats relevant to our business.

As of the filing of this Form 10-K, we are not aware of any cybersecurity incidents that have occurred since the beginning of 2025 that have materially affected, or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. We describe whether any risks from cybersecurity threats, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition, under the heading “Our business could suffer if information technology systems are disrupted, cease to operate effectively or become subject to a cybersecurity incident.” included within our risk factor disclosures in Item 1A. Risk Factors of this Annual Report on Form 10-K, which information is incorporated herein by reference.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] We have developed processes to assess, identify and manage our risks related to cybersecurity threats which are incorporated into the Company’s overall risk management process. On an ongoing basis we utilize threat prevention systems to monitor, block and protect our information technology systems which are monitored continuously by trained security personnel. Our process to prevent cybersecurity incidents involves layered security architecture designed to protect our networks, end-user devices, servers, and cloud solutions. On a regular basis, we conduct phishing email simulations and provide training resources to our employees. We have an Incident Response Plan to outline our process to manage cybersecurity threats and incidents.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity is among our Board’s oversight priorities. Through their oversight role, the Board has allocated oversight of cybersecurity risk to our Audit Review Committee of the Board. Our Audit Review Committee plays a vital role in our cybersecurity risk management process and regularly reviews the Company’s cybersecurity and other information technology risks, controls and procedures. Throughout the year, management provides the Audit Review Committee with updates to our cybersecurity risk management process and our security monitoring and protection systems. The Audit Review Committee is kept informed of new security solutions planned for deployment. As part of their regular review of reports from management, the Audit Review Committee regularly reports cybersecurity risk updates to the Board, which enables the Board to incorporate the insights of such reports into its overall risk oversight analysis.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity is among our Board’s oversight priorities. Through their oversight role, the Board has allocated oversight of cybersecurity risk to our Audit Review Committee of the Board.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Our Audit Review Committee plays a vital role in our cybersecurity risk management process and regularly reviews the Company’s cybersecurity and other information technology risks, controls and procedures. Throughout the year, management provides the Audit Review Committee with updates to our cybersecurity risk management process and our security monitoring and protection systems. The Audit Review Committee is kept informed of new security solutions planned for deployment. As part of their regular review of reports from management, the Audit Review Committee regularly reports cybersecurity risk updates to the Board, which enables the Board to incorporate the insights of such reports into its overall risk oversight analysis.
Cybersecurity Risk Role of Management [Text Block]
Our cybersecurity risk management processes are led by our VP, Information Technology, and Group Manager, Security and Infrastructure and the Company has implemented security and privacy policies across multiple infrastructure and application platforms as well as identity and access management enhancements. The VP, Information Technology has many years of experience in various roles involving managing information systems and cybersecurity functions and developing cybersecurity strategies. In order to enable the Company to prevent, detect, mitigate and remediate cybersecurity incidents, our security monitoring and protection systems are continuously monitored. The VP, Information Technology, is kept informed in accordance with our Incident Response Plan and reports matters to the Audit Review Committee as necessary.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our cybersecurity risk management processes are led by our VP, Information Technology,
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] The VP, Information Technology has many years of experience in various roles involving managing information systems and cybersecurity functions and developing cybersecurity strategies.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] In order to enable the Company to prevent, detect, mitigate and remediate cybersecurity incidents, our security monitoring and protection systems are continuously monitored. The VP, Information Technology, is kept informed in accordance with our Incident Response Plan and reports matters to the Audit Review Committee as necessary.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation The accompanying consolidated financial statements include the financial statements of the Company and have been prepared in accordance with U.S. generally accepted accounting principles (GAAP).
Principles of Consolidation Intercompany balances and transactions have been eliminated.
Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and disclosure of contingent assets and liabilities (if any). Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents

Cash and cash equivalents include cash in banks and highly liquid investments with original maturities of three months or less.
U.S. Treasury Bills
U.S. Treasury Bills
During the third quarter of 2024, the Company invested $9.8 million of excess cash on hand into two U.S. Treasury Bills with original maturities of three and six months. U.S. Treasury Bills with an original maturity of 3 months or less are included within cash and cash equivalents on the Consolidated Balance Sheets and those greater than 3 months but less than one year are included within prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company classified these U.S. Treasury Bills as held-to-maturity as it intended to hold these securities until maturity. Held-to-maturity debt securities are recorded at amortized cost. Discounts from and premiums to par value on held-to-maturity debt securities are accreted/amortized into interest income over the life of the respective security using the effective interest method. The Company evaluates for other than temporary impairment on an ongoing basis. No impairment has been recognized for investments in debt securities for any period presented. As of December 31, 2025 and 2024, the amortized cost and net carrying value of the security recognized in prepaid expenses and other current assets was $0 and $5.0 million, respectively. There were no U.S. Treasury Bills recognized within cash and cash equivalents on the Consolidated Balance Sheets as of December 31, 2025 or 2024.
Trade Receivables
Trade Receivables

Allowances for credit losses are maintained against trade receivables for estimated losses resulting from the inability of customers to make required payments. These allowances are based on both recent trends of certain customers estimated to be a greater credit risk as well as general trends of the entire customer pool. Accounts are written off against the allowance when it becomes evident collection will not occur.
The Company maintains significant trade receivables balances with several large retail customers.
Accounts payable - Supplier Finance Program
Accounts payable - Supplier Finance Program
The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements. The agreement has a limit of $65.0 million in payment obligations. There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party administrator based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows.
Transfer of Financial Assets
Transfer of Financial Assets

The Company has entered into an arrangement with a financial institution to sell certain U.S. trade receivables on a non-recourse basis. Under the terms of the agreement, the Company receives cash proceeds and retains no rights or interest and has no obligations with respect to the sold receivables. These transactions, which are accounted for as sold receivables, result in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $145.0 million and $149.7 million of trade receivables during 2025 and 2024, respectively. The losses incurred on sold receivables in the Consolidated Statements of Operations for the years ended December 31, 2025, 2024 and 2023 were not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities.
Inventory
Inventory

Inventory is stated at the lower of cost or net realizable value with cost determined under the first-in, first-out (“FIFO”) method. Adjustments to the carrying value are recorded for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions.
Property, Plant and Equipment
Property, Plant and Equipment

Property, plant and equipment are measured at cost less accumulated depreciation, amortization and accumulated impairment losses. Depreciation and amortization are recorded generally using the straight-line method over the estimated useful lives of the assets. Estimated lives for buildings are up to 40 years, and for machinery, equipment and furniture and fixtures range from three to seven years. Leasehold improvements are depreciated over the shorter of the estimated useful life or the term of the lease. The units-of-production method is used to amortize certain tooling for sourced products. Costs incurred to develop software for internal use are capitalized and amortized over the estimated useful life of the software. If the useful life of property, plant and equipment is reassessed during any period, the Company recognizes accelerated depreciation expense in accordance with the reduced expected holding period of the asset. Gains or losses from the sale of assets are included in selling, general and administrative expenses. Repairs and maintenance are charged to expense as incurred. Interest is capitalized for qualifying long-term capital asset projects as a part of the historical cost of acquiring the asset.
The Company evaluates long-lived assets for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount exceeds the fair value of the asset. Fair value is estimated at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
Goodwill and Intangible Assets
Goodwill and Intangible Assets

Goodwill represents the excess of the purchase price of acquisitions over the estimated fair value of the net assets acquired. Goodwill is not amortized but evaluated at least annually for impairment. The Company conducts its annual test for impairment as of October 1 of each year and it may be conducted more frequently if changes in circumstances or the occurrence of events indicates that a potential impairment exists. The Company may elect to perform a qualitative assessment that considers economic, industry, and company-specific factors for all or selected reporting units. If, after completing this assessment, it is determined that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value, the Company would proceed to a quantitative test. The Company may also elect to perform a quantitative test instead of a qualitative assessment for any or all of the reporting units. For the quantitative test, the Company determines the estimated fair value through the use of both a market-based approach and a discounted cash flow valuation model incorporating discount rates commensurate with the risks involved for each reporting unit. The assumptions used in the discounted cash flow valuation model for impairment testing includes discount rates, revenue growth rates and operating profit margin rates, and terminal growth rates. If the estimated fair value of the reporting unit is less than the current carrying value, impairment of goodwill of the reporting unit is recognized.

The impairment assessment is performed at the reporting unit level. The Company’s reporting units have been identified at the operating segment level.

Intangible assets with finite lives are amortized over their estimated useful lives, which represent the period over which the asset is expected to contribute directly or indirectly to future cash flows. Intangible assets with finite lives are reviewed for impairment whenever events and circumstances indicate the carrying value of such assets may not be recoverable and exceed their fair value. If an impairment loss exists, the carrying amount of the intangible asset is adjusted to a new cost basis. The new cost basis is amortized over the remaining useful life of the asset.
Environmental Liabilities
Environmental Liabilities

The Company and environmental consultants are investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses the Company has acquired. Liabilities for environmental matters are recorded in the period when it is determined to be probable and reasonably estimable that the Company will incur costs. When only a range of amounts is reasonably estimable and no amount within the range is more probable than another, the Company records the low end of the range. Environmental liabilities are recorded on an undiscounted basis and associated expense is recorded in selling, general and administrative expenses. When recovery of a portion of an environmental liability is probable, such amounts are recognized as a reduction to selling, general and administrative expenses and included in prepaid expenses and other current assets (current portion) and other non-current assets until settled.
Revenue Recognition
Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales taxes are excluded from revenue. At contract inception, the Company assesses the goods and services promised in its contracts with customers and identifies a performance obligation for each promised good or service that is distinct. The Company has elected to account for shipping and handling activities performed after a customer obtains control of the goods as activities to fulfill the promise to transfer the goods, and therefore these activities are not assessed as a separate service to customers. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company determines whether price concessions offered to its customers are a reduction of the transaction price and revenue or are advertising expense, depending on whether the Company receives a distinct good or service from its customers and, if so, whether the Company can reasonably estimate the fair value of that distinct good or service. The Company evaluated such agreements with its customers and determined they should be accounted for as variable consideration.

To estimate variable consideration, the Company applies both the expected value method and most likely amount method based on the form of variable consideration, according to which method would provide the better prediction. The expected value method involves a probability weighted determination of the expected amount, whereas the most likely amount method identifies the single most likely outcome in a range of possible amounts.
Product Development Costs
Product Development Costs
Expenses associated with the development of new products and changes to existing products are charged to expense as incurred.
Foreign Currency
Foreign Currency

Assets and liabilities of foreign operations are translated into U.S. dollars at the fiscal year-end exchange rate. Revenue and expenses of all foreign operations are translated using average monthly exchange rates prevailing during the year. The related translation adjustments, including translation on long-term intra-entity foreign currency transactions, are recorded as a separate component of stockholders’ equity.
Financial Instruments
Financial Instruments

Financial instruments held by the Company include cash and cash equivalents, U.S. Treasury Bills, trade receivables, accounts payable, revolving credit agreements, interest rate swap agreements and forward foreign currency exchange contracts. The Company does not hold or issue financial instruments or derivative financial instruments for trading purposes. Interest rate swap agreements and forward foreign currency exchange contracts held by the Company have been designated as hedges of forecasted cash flows. The Company holds these derivative contracts with high-quality financial institutions and limits the amount of credit exposure to any one institution. The Company does not currently hold any nonderivative instruments designated as hedges or any derivatives designated as fair value hedges.
The Company uses forward foreign currency exchange contracts to partially reduce risks related to transactions denominated in foreign currencies. The Company offsets fair value amounts related to foreign currency exchange contracts executed with the same counterparty. These contracts hedge firm commitments and forecasted transactions relating to cash flows associated with sales and purchases denominated in currencies other than the subsidiaries’ functional currencies. Changes in the fair value of forward foreign currency exchange contracts that are effective as hedges are recorded in accumulated other comprehensive income (loss) (“AOCI”). Deferred gains or losses are reclassified from AOCI to the Consolidated Statements of Operations in the same period as the gains or losses from the underlying transactions are recorded and are generally recognized in cost of sales.

The Company uses interest rate swap agreements to partially reduce risks related to floating rate financing agreements that are subject to changes in the market rate of interest. Terms of the interest rate swap agreements require the Company to receive a variable interest rate and pay a fixed interest rate. The Company’s interest rate swap agreements and its variable rate financings are predominately based upon SOFR (Secured Overnight Financing Rate). For cash flow hedges, the Company formally assesses, both at inception and on a quarterly basis thereafter, whether the designated derivative instrument is highly effective in offsetting changes in cash flows of the hedged item. Changes in the fair value of interest rate swap agreements that are effective as hedges are recorded in AOCI. Deferred gains or losses are reclassified from AOCI to the Consolidated Statements of Operations in the same period as the gains or losses from the underlying transactions are recorded and are generally recognized in interest expense, net. The Company discontinues hedge accounting prospectively when the derivative is not highly effective as a hedge, the underlying hedged transaction is no longer probable or the hedging instrument expires, is sold, terminated or exercised.

The Company periodically enters into foreign currency exchange contracts that do not meet the criteria for hedge accounting. These derivatives are used to reduce the Company’s exposure to foreign currency risk related to forecasted purchase or sales transactions or forecasted intercompany cash payments or settlements. Gains and losses on these derivatives are included in other expense, net.

Cash flows from hedging activities are reported in the Consolidated Statements of Cash Flows in the same classification as the hedged item, generally as a component of cash flows from operations.
Fair Value Measurements
Fair Value Measurements

The Company defines the fair value measurement of its financial assets and liabilities as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

A fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value.

Described below are the three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.
Level 2 - Observable prices that are based on inputs not quoted on active markets but corroborated by market data.
Level 3 - Unobservable inputs are used when little or no market data is available.

The hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement.
Stock Compensation
Stock Compensation

Pursuant to the Executive Long-Term Equity Incentive Plan (the “Executive Plan”) established in September 2017, and amended and restated in March 2024, the Company grants shares of Class A Common, subject to transfer restrictions, as a means of retaining and rewarding selected employees for long-term performance. Shares awarded under the Executive Plan are fully vested and entitle the stockholder to all rights of common stock ownership except that shares may not be assigned, pledged or otherwise transferred during the restriction period. In general, the restriction period ends after three, five or ten years from the award date or at the earliest of (1) three years after the participant’s retirement date, or (2) the participant’s death or permanent disability. The Company issued 306,039, 241,947 and 169,227 shares of Class A Common in the years ended December 31, 2025, 2024 and 2023, respectively. After the issuance of these shares, there were 705,355 shares of Class A Common available for issuance under this plan. Stock compensation expense related to the Executive Plan was $2.8 million, $5.1 million and $4.2 million for the years ended December 31, 2025, 2024 and 2023, respectively, and was based on the fair value of Class A Common on the grant date.

The Company also has a stock compensation plan for non-employee directors of the Company under which a portion of the annual retainer for each non-employee director is paid in transfer-restricted shares of Class A Common. For the years ended December 31, 2025 and 2024, $112,000 and $110,000, respectively, ($150,000 for the Chairman) of the non-employee director’s annual retainer of $179,000 and $175,000, respectively, ($250,000 for the Chairman) was paid in transfer-restricted shares of Class A Common. Shares awarded under the plan are fully vested and entitle the stockholder to all rights of common stock ownership except that shares may not be assigned, pledged or otherwise transferred during the restriction period. In general, the transfer restriction period ends at the earliest of (1) ten years after the Quarter Date with respect to which such Required Shares were issued or transferred, (2) the date of the director’s death or date the director terminates service as a director due to permanent disability, (3) five years (or earlier with the approval of the Board) after the director’s date of retirement from the Board, or (4) the date the director has both retired from the Board and has reached age 70. Pursuant to this plan, the Company issued 71,999, 60,235 and 100,238 shares in the years ended December 31, 2025, 2024 and 2023, respectively. In addition to the mandatory retainer fee received in transfer-restricted stock, directors may elect to receive shares of Class A Common in lieu of cash for up to 100% of the balance of their annual retainer, committee retainer and any committee chairman’s fees. These voluntary shares are not subject to any restrictions. There were no shares issued under voluntary elections in 2025, 2024 and 2023. After the issuance of these shares, there were 361,174 shares of Class A Common available for issuance under this plan. Stock compensation expense related to these awards was $1.3 million, $1.2 million and $1.2 million for the years ended December 31, 2025, 2024 and 2023, respectively. Stock compensation expense represents fair value based on the market price of the shares of Class A Common on the grant date.
Leases
Leases

Lessee

In accordance with Accounting Standards Codification 842, the Company determines whether an arrangement is a lease at inception, considering whether the contract conveys a right to control the use of the identified asset for a period of time in exchange for consideration. Leases are classified as operating or finance leases at the commencement date of the lease. Operating leases are included in Right-of-use lease assets, Lease liabilities and Lease liabilities, non-current on the Consolidated Balance Sheets.

Right-of-use lease assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. Lease liabilities are classified between current and non-current liabilities based on their contractual payment terms. The right-of-use lease asset includes prepaid rent and reflects the unamortized balance of lease incentives. The Company’s leases may include renewal options, and the renewal option is included in the lease term if it is concluded that it is reasonably certain that we will exercise that option. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company has operating leases for real estate, equipment and production specific tooling assets used by our third-party suppliers. The Company has finance leases for certain equipment. The Company has elected not to record short-term leases with initial terms of twelve months or less in its Consolidated Balance Sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Lease expense for finance leases is recognized on a straight-line basis over the lease term unless a purchase option is exercised to transfer title at the end of the lease term in which case the expense is amortized over the useful life of the asset. Variable lease payments that do not depend on an index or a rate, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, insurance and property taxes, are excluded from the measurement of the lease liability, unless subject to fixed minimum requirements, and are recognized as variable lease cost when the obligation for that payment is incurred. The Company combines lease and non-lease components as a single component for all asset classes. Lease expense is classified as cost of sales or selling, general and administrative expenses in its Consolidated Statements of Operations based on the use of the leased item.

As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company’s estimated incremental borrowing rate reflects a secured rate based on recent debt issuances, its estimated credit rating, lease term, as well as publicly available data for instruments with similar characteristics.

Lessor

The Company is the lessor of connected devices to specialty pharmacy networks and pharmaceutical companies. The devices are leased on a month-to-month basis and therefore are short-term leases. These leases are classified as operating leases. There are no options to purchase the device at the end of the term. Revenue is recognized on a straight-line basis based on quantity of connected devices in service during the month. The Company combines lease and non-lease components as a single component for all asset classes.
Treasury Stock
Treasury Stock
The Company records the aggregate purchase price of treasury stock at cost and includes treasury stock as a reduction to stockholders’ equity.
Income Taxes
Income Taxes

Tax law requires certain items to be included in the tax return at different times than the items are reflected in the financial statements. Some of these differences are permanent, such as expenses that are not deductible for tax purposes, and some differences are temporary, reversing over time, such as depreciation expense. These temporary differences create deferred tax assets and liabilities using currently enacted tax rates. The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year, and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the financial statements or tax returns. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date. The Company is required to estimate the timing of the recognition of deferred tax assets and liabilities, make assumptions about the future deductibility of deferred tax assets and assess deferred tax liabilities based on enacted law and tax rates for the appropriate tax jurisdictions to determine the amount of such deferred tax assets and liabilities. Changes in the calculated deferred tax assets and liabilities may occur in certain circumstances, including statutory income tax rate changes, statutory tax law changes or changes in the Company’s structure or tax status.

The Company’s tax assets, liabilities and tax expense are supported by historical earnings and losses and the Company’s best estimates and assumptions of future earnings by jurisdiction. The Company assesses whether a valuation allowance should be established against the Company’s deferred tax assets based on consideration of all available evidence, both positive and negative, using a more likely than not standard. This assessment considers, among other matters, scheduled reversals of deferred tax liabilities, projected future taxable income, tax-planning strategies and results of recent operations. The assumptions about future taxable income require significant judgment and are consistent with the plans and estimates the Company is using to manage the underlying businesses. When the Company determines, based on all available evidence, that it is more likely than not that deferred tax assets will not be realized, a valuation allowance is established.
Accounting Standards Adopted and Recently Issued Accounting Standards
Accounting Standards Adopted

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which enhances income tax disclosure requirements primarily involving more detailed disclosure for income taxes paid and the effective tax rate reconciliation. The Company adopted ASU 2023-09 prospectively for the annual period beginning January 1, 2025, and it affects only our disclosures and does not impact our results of operations or financial condition.

Recently Issued Accounting Standards

In November 2024, the FASB issued ASU 2024-03, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40),” which requires additional information to be disclosed about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.

In July 2025, the FASB issued ASU 2025-05, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which provides a practical expedient in estimating credit losses for current accounts receivables and current contract assets arising from transactions accounted for under Topic 606 that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. The amendments are effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, “Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40):Targeted Improvements to the Accounting for Internal-Use Software,” which modernizes previously written guidance around internal-use software costs by eliminating accounting consideration of software project development stages and provides for cost capitalization when management has authorized and committed funding to the project and that the project is considered ‘probable’ of completion and the software used to perform the function as intended, along with prescriptive disclosure requirements associated with internal-use software costs to be consistent with Subtopic 360-10, “Property, Plant and Equipment” regardless of how those costs are presented in the financial statements. The amendments are effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The amendment may be applied either retrospectively or prospectively or on a modified prospective basis prescribed by the ASU. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule Of Supplier Finance Program
A rollforward of the Company’s outstanding payment obligations confirmed as valid under our supplier finance program for the period shown were as follows:


 2025
Confirmed obligations outstanding as of January 1$56,940 
Invoices confirmed during the year170,263 
Confirmed invoices paid during the year(197,327)
Confirmed obligations outstanding as of December 31$29,876 
v3.25.4
Property, Plant and Equipment, Net (Tables)
 12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment, Net [Abstract]  
Schedule of Property, Plant and Equipment, Net
Property, plant and equipment, net includes the following:
 December 31
 20252024
Land$226 $226 
Furniture and fixtures10,146 9,946 
Building and improvements9,583 9,511 
Machinery and equipment33,523 33,021 
Internal-use capitalized software16,696 15,867 
Construction in progress1,696 2,180 
Property, plant and equipment, at cost71,870 70,751 
Less allowances for depreciation and amortization41,617 36,350 
 $30,253 $34,401 
v3.25.4
Goodwill and Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
Intangible assets other than goodwill, which are subject to amortization, consist of the following:

 Gross Carrying
Amount		Accumulated
Amortization		Net
Balance
Balance as of December 31, 2025
   
Trademarks$3,100 $(2,208)$892 
Developed technology1,424 (223)1,201 
$4,524 $(2,431)$2,093 
Balance as of December 31, 2024
   
Trademarks$3,100 $(2,008)$1,092 
Developed technology1,111 (102)1,009 
$4,211 $(2,110)$2,101 
v3.25.4
Current and Long-Term Financing (Tables)
 12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Debt
The following table summarizes HBB’s available and outstanding borrowings:
 December 31
 20252024
Total outstanding borrowings:  
Revolving credit agreements$50,000 $50,000 
Total outstanding borrowings$50,000 $50,000 
Total available borrowings, net of limitations, under revolving credit agreements$123,783 $107,257 
  
Unused available borrowings$73,783 $57,257 
  
Weighted average stated interest rate on total borrowings5.94 %5.20 %
Weighted average effective interest rate on total borrowings (including interest rate swap agreements)3.30 %2.50 %
v3.25.4
Derivative Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Interest Rate Derivatives
The following table summarizes the notional amounts, related rates and remaining terms of interest rate swap agreements for HBB as of December 31, in millions:
 Notional Amount Average Fixed RateRemaining Term at
 2025202420252024December 31, 2025
Interest rate swaps$50.0 $50.0 1.6 %1.6 %Extending to January 2029
Schedule of the Fair Value of Derivative Instruments Recorded in the Consolidated Balance Sheets
The following table summarizes the fair value of derivative instruments as of December 31, as recorded in the Consolidated Balance Sheets:
 Asset DerivativesLiability Derivatives
 Balance sheet location20252024Balance sheet location20252024
Interest rate swap agreements      
CurrentPrepaid expenses and other current assets$831 $1,144 Other current liabilities$— $— 
Long-termOther non-current assets1,199 2,808 Other long-term liabilities— — 
Foreign currency exchange contracts      
CurrentPrepaid expenses and other current assets— 789 Other current liabilities126 — 
Total derivatives $2,030 $4,741  $126 $— 
v3.25.4
Leasing Arrangements (Tables)
 12 Months Ended
Dec. 31, 2025
Lessee Disclosure [Abstract]  
Schedule of Lease Cost, Supplemental Cash Flow and Non-cash Information
December 31
20252024
Operating lease cost$7,172 $8,112 
Finance lease cost
Amortization of leased assets74 72 
Interest on lease liabilities22 28 
Finance lease cost96 100 
Variable lease cost (1)
318,309 368,948 
Short term lease cost (2)
46 52 
Total lease cost$325,623 $377,212 

(1) Amounts primarily reflect product purchases that are associated with production related tooling.
(2) Leases with an initial term of 12 months or less
The following table presents supplemental cash flow and non-cash information related to leases:
December 31
20252024
Cash paid for amounts included in the measurement of lease liabilities – operating cash flows from leases$8,066 $8,799 
Right-of-use assets obtained in exchange for lease obligations of operating leases – non-cash activity$3,397 $2,624 
Right-of-use assets obtained in exchange for lease obligations of finance leases – non-cash activity$6 $73 
The following table summarizes the weighted-average lease term and discount rate.
December 31
20252024
Weighted average remaining lease term in years - operating leases7.38.3
Weighted average remaining lease term in years - finance leases2.63.6
Weighted average discount rate - operating leases (1)
5.2 %5.1 %
Weighted average discount rate - finance leases (1)
7.3 %7.3 %
(1) The discount rates used to present value the lease liabilities are based on estimates of the Company’s incremental borrowing rate.
Schedule of Future Lease Payments for Operating Leases
The following table reconciles the undiscounted future lease payments for operating and finance leases to the lease liabilities recorded in the Consolidated Balance Sheet as of December 31, 2025:
Undiscounted Future Lease Payments
2026$7,530 
20277,079 
20286,661 
20296,493 
20305,791 
Thereafter16,889 
Total lease payments50,443 
Less: impact of discounting8,530 
Present value of lease payments$41,913 
v3.25.4
Stockholders' Equity and Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Stock by Class
The following table sets forth the Company’s authorized capital stock information:
December 31
20252024
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 
Preferred stock outstanding— — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 
Class A Common issued(1)(2)
11,870 11,476 
Treasury Stock(3)
2,052 1,545 
Class B Common stock, par value $0.01 per share, convertible into Class A on a one-for-one basis
Class B Common authorized30,000 30,000 
Class B Common issued(1)
3,587 3,603 
(1)    Class B Common converted to Class A Common were 16 shares during 2025 and 13 shares during 2024.
(2)     The Company issued Class A Common of 378 during 2025 and 302 during 2024 related to the Company’s stock compensation plan.
(3)     On February 21, 2025 and March 5, 2024, a total of 39 and 30 mandatory cashless-exercise-award shares of Class A Common, respectively, were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan.
Schedule of Reclassification out of Accumulated Other Comprehensive Income (Loss)
The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown:
Foreign CurrencyDeferred Gain (Loss) on Cash Flow HedgingPension Plan AdjustmentTotal
Balance, January 1, 2023$(8,924)$4,158 $(7,152)$(11,918)
Other comprehensive income (loss)2,792 (4,529)141 (1,596)
Reclassification adjustment to net income (loss)— 2,231 474 2,705 
Tax effects(280)564 (142)142 
Balance, December 31, 2023$(6,412)$2,424 $(6,679)$(10,667)
Other comprehensive income (loss)(5,867)3,256 1,344 (1,267)
Reclassification adjustment to net income (loss)— (1,629)7,805 6,176 
Tax effects— (479)(2,340)(2,819)
Balance, December 31, 2024$(12,279)$3,572 $130 $(8,577)
Other comprehensive income (loss)3,914 (2,191)279 2,002 
Reclassification adjustment to net income (loss)— (1,204)170 (1,034)
Tax effects— 919 (90)829 
Balance, December 31, 2025$(8,365)$1,096 $489 $(6,780)
Schedule of Earnings (Loss) Per Share
The weighted average number of shares of Class A Common and Class B Common outstanding used to calculate basic and diluted earnings (loss) per share were as follows:
 202520242023
Basic weighted average shares outstanding13,552 13,950 14,036 
Dilutive effect of share-based compensation awards19 13 24 
Diluted weighted average shares outstanding13,571 13,963 14,060 
Basic and diluted earnings (loss) per share$1.95 $2.20 $1.80 
v3.25.4
Revenue (Tables)
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table sets forth the Company’s revenue on a disaggregated basis for the year ended:
Year Ended
December 31
 202520242023
Consumer products$532,373 $592,801 $568,006 
Commercial products59,898 51,755 52,327 
Licensing8,909 6,917 5,292 
Leasing5,672 3,220 — 
     Total revenues$606,852 $654,693 $625,625 
v3.25.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (Benefit)
The components of income (loss) before income taxes and the income tax expense (benefit) for the years ended December 31 are as follows:
 202520242023
Income (loss) before income taxes  
Domestic$32,980 $33,403 $24,008 
Foreign2,661 (27)7,688 
$35,641 $33,376 $31,696 
Income tax expense (benefit)  
Current income tax expense (benefit):  
Federal$2,555 $8,457 $3,412 
State1,142 2,790 1,452 
Foreign1,736 (1,361)2,496 
Total current5,433 9,886 7,360 
Deferred income tax expense (benefit):  
Federal3,434 (4,573)910 
State703 (998)(9)
Foreign(384)(1,698)(1,807)
Total deferred3,753 (7,269)(906)
 $9,186 $2,617 $6,454 
Schedule of Cash Paid for Income Taxes (Net of Refunds)
Total cash paid for income taxes (net of refunds) by jurisdiction for the year ended December 31, 2025 is as follows:
 2025
 
U.S. Federal$6,890 
State$2,830 
Foreign: 
Canada$826 
Mexico2,612 
Other217 
Foreign Subtotal$3,655 
Total cash paid for income taxes (net of refunds)$13,375 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the federal statutory and effective income tax rate for the year ended December 31, 2025 is as follows:
2025
 $%
Income (loss) before income taxes$35,641 
Statutory taxes at 21%
$7,485 21.0 %
State and local income taxes1,602 4.5 %
Foreign tax effects794 2.2 %
Effect of cross-border tax laws(702)(2.0)%
U.S. tax credits(962)(2.7)%
Valuation allowances166 0.5 %
Non-deductible expenses related to sec. 162(m)812 2.3 %
Unrecognized tax benefits(9)— %
Income tax provision$9,186 25.8 %
Effective rate25.77 %
State taxes in Virginia, California, Illinois, and Pennsylvania made up the majority (greater than 50 percent) of the tax effect in the "State and Local Income Tax" category.

A reconciliation of the federal statutory and effective income tax rate for the years ended December 31, 2024 and 2023 are as follows:

20242023
 $%$%
Income (loss) before income taxes$33,376 $31,696 
Statutory taxes at 21%
$7,009 21.0 %$6,656 21.0 %
State and local income taxes1,610 4.8 %1,224 3.9 %
Valuation allowances635 1.9 %13 0.1 %
Other non-deductible expenses1,196 3.6 %402 1.3 %
Credits(1,148)(3.4)%(860)(2.7)%
Effect of foreign operations (1)
(4,330)(13.1)%(946)(3.0)%
Unrecognized tax benefits(32)(0.1)%422 1.3 %
Accounting method change (2)
(2,278)(6.8)%— — %
Other, net(45)(0.1)%(457)(1.5)%
Income tax provision$2,617 7.8 %$6,454 20.4 %
Effective rate7.84 %20.36 %

(1) The 2024 period includes a tax benefit for deducting certain historical foreign operating losses.
(2) During the fourth quarter of 2024, the Company filed IRS form 3115 Application for Change in Accounting Method, for depreciation. The result of the filing was a benefit of $2.3 million.
Schedule of Deferred Tax Assets and Liabilities
A detailed summary of the total deferred tax assets and liabilities in the Company’s Consolidated Balance Sheets resulting from differences in the book and tax basis of assets and liabilities follows:
 December 31
 20252024
Deferred tax assets  
Tax carryforwards$7,126 $5,982 
Lease liabilities1,797 2,003 
Inventory3,014 802 
Accrued expenses and reserves3,670 2,963 
Other employee benefits527 259 
Depreciation and amortization— 3,646 
Other— 32 
Total deferred tax assets16,134 15,687 
Less: Valuation allowances(7,126)(5,982)
 9,008 9,705 
Deferred tax liabilities  
Accrued pension benefits2,754 3,373 
Depreciation and amortization2,636 — 
Other11 — 
Total deferred tax liabilities5,401 3,373 
Net deferred tax asset $3,607 $6,332 
Schedule of Tax Credit Carryforwards
The following table summarizes the tax carryforwards and associated carryforward periods and related valuation allowances where the Company has determined that realization is uncertain:
 December 31, 2025
 Net deferred tax
asset		Valuation
allowance		Carryforwards
expire during:
Non-U.S. net operating loss$6,960 $6,960 2026 - Indefinite
U.S. capital loss$166 $166 2030
Total$7,126 $7,126 

 December 31, 2024
 Net deferred tax
asset		Valuation
allowance		Carryforwards
expire during:
Non-U.S. net operating loss$5,982 $5,982 2025 - Indefinite
Schedule of Unrecognized Tax Benefits Roll Forward
The following is a reconciliation of the Company’s total gross unrecognized tax benefits, defined as the aggregate tax effect of differences between tax return positions and the benefits recognized in the financial statements for the years ended December 31, 2025, 2024 and 2023. Approximately $0.6 million, $0.6 million and $1.4 million of these gross amounts as of December 31, 2025, 2024 and 2023, respectively, relate to permanent items that, if recognized, would impact the effective income tax rate.
 202520242023
Balance as of January 1$618 $1,447 $256 
Additions (reductions) based on tax positions related to prior years(39)(769)769 
Additions (reductions) based on tax positions related to the current year— — 493 
Reductions for lapse of statute of limitations— (60)(71)
Reductions due to settlements with taxing authorities— — — 
Balance as of December 31$579 $618 $1,447 
v3.25.4
Retirement Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Assumptions Used in Accounting for the Defined Benefit Plan
The weighted-average assumptions used in accounting for the defined benefit plans were as follows for the years ended December 31:
 20242023
U.S. Pension Plan
 
Discount rate for pension benefit obligationn/a5.01 %
Discount rate for net periodic benefit (income) expensen/a5.34 %
Expected long-term rate of return on assets for net periodic pension (income) expensen/a4.00 %
 202520242023
Canada Pension Plan
Discount rate for pension benefit obligation4.67 %4.58 %4.63 %
Discount rate for net periodic benefit (income) expense4.58 %4.63 %5.15 %
Expected long-term rate of return on assets for net periodic pension (income) expense6.00 %6.00 %6.00 %
Schedule of Net Periodic Benefit Income and Expense for the Defined Benefit Plan
Set forth below is a detail of the net periodic pension (income) expense, included in other expense (income), net for the defined benefit plans for the years ended December 31:

 20242023
U.S. Pension Plan
Interest cost$379 $674 
Expected return on plan assets(521)(1,082)
Amortization of actuarial loss238 358 
Settlement loss7,611 — 
Net periodic pension (income) expense$7,707 $(50)

 202520242023
Canada Pension Plan
Interest cost$140 $147 $162 
Expected return on plan assets(271)(263)(258)
Amortization of actuarial loss (gain)108 (44)118 
Net periodic pension (income) expense$(23)$(160)$22 
Schedule of Changes in Plan Assets and Benefit Obligations Recognized in Comprehensive Loss (Income)
Set forth below is the detail of other changes in plan assets and benefit obligations (pre-tax) recognized in other comprehensive loss (income) for the years ended December 31:

 20242023
U.S. Pension Plan
Current year actuarial loss (gain)$(998)$(33)
Settlement loss(7,611)— 
Amortization of actuarial loss(238)(358)
Total recognized in other comprehensive loss (income)$(8,847)$(391)

 202520242023
Canada Pension Plan
Current year actuarial loss (gain)$(279)$(346)$(108)
Amortization of actuarial (loss) gain(108)44 (118)
Total recognized in other comprehensive loss (income)$(387)$(302)$(226)
Schedule of Changes in Benefit Obligations during the year and Funded Status of Defined Benefit Plan
The following table sets forth the changes in the benefit obligation and the plan assets during the year and the funded status of the defined benefit plans as of December 31:
 20252024
 U.S. Pension PlanCanada Pension PlanU.S. Pension PlanCanada Pension Plan
Change in benefit obligation    
Projected benefit obligation at beginning of year$104 $3,077 $12,916 $3,401 
Interest cost— 140 379 147 
Annuity purchase refund— — 441 — 
Actuarial (gain) loss— (79)(1,610)18 
Benefits paid— (215)(1,030)(217)
Settlements(104)— (10,992)— 
Foreign currency exchange rate changes— 149 — (272)
Projected benefit obligation at end of year$— $3,072 $104 $3,077 
Accumulated benefit obligation at end of year$— $3,072 $104 $3,077 
Change in plan assets    
Fair value of plan assets at beginning of year$13,485 $4,505 $25,156 $4,654 
Actual return on plan assets— 466 (90)645 
Benefits paid— (215)(1,030)(217)
Annuity purchase refund— — 441 — 
Settlements— — (10,992)— 
Other— (172)— (189)
Foreign currency exchange rate changes— 226 — (388)
Transfer to qualified replacement plan (1)
(13,485)— — — 
Fair value of plan assets at end of year$— $4,810 $13,485 $4,505 
Funded status at end of year$— $1,738 $13,381 $1,428 
Amounts recognized in the balance sheets consist of:    
Deferred costs$— $1,738 $13,381 $1,428 
Components of accumulated other comprehensive loss consist of:  
Actuarial loss$— $592 $(62)$205 
Deferred taxes— (103)16 (29)
 $— $489 $(46)$176 
(1) During the first quarter of 2025, the Company transferred $13.4 million of U.S. Pension Plan surplus assets to a qualified replacement plan.
Schedule of Future Benefit Payments
Future pension benefit payments expected to be paid from assets of the Canada Pension Plan are:
 Canada Pension Plan
2026$241 
2027250 
2028247 
2029243 
2030236 
2031-20351,114 
 $2,331 
Schedule of Actual and Target Allocation Percentage for Pension Plan Assets
The following is the actual allocation percentage and target allocation percentage for the Canada Pension Plan assets as of December 31:
 
2025
Actual
Allocation
2024
Actual
Allocation
Target Allocation
Range
Canadian equity securities36.3 %32.7 %
25.0% - 35.0%
Non-Canadian equity securities41.0 %37.7 %
25.0% - 35.0%
Fixed income securities22.7 %29.6 %
30.0% - 50.0%
Schedule of Fair Value of Pension Plan Assets Following are the values as of December 31:
Canada Pension Plan
 20252024
U.S. equity securities$1,683 $1,458 
Non-U.S. equity securities2,033 1,714 
Fixed income securities1,094 1,333 
Total$4,810 $4,505 
v3.25.4
Data by Geographic Region (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas
Revenue and property, plant and equipment related to operations outside the U.S., based on customer and asset location, are as follows:
 U.S.OtherConsolidated
2025   
Revenue from unaffiliated customers $458,847 $148,005 $606,852 
Property, plant and equipment, net$23,560 $6,693 $30,253 
2024
Revenue from unaffiliated customers$511,248 $143,445 $654,693 
Property, plant and equipment, net$26,730 $7,671 $34,401 
2023
Revenue from unaffiliated customers $493,711 $131,914 $625,625 
Property, plant and equipment, net$23,068 $4,333 $27,401 
v3.25.4
Segment Reporting (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
The table below presents the revenues and significant expenses of the two reportable segments along with a reconciliation of segment profit (loss) to consolidated income (loss) before income taxes. Total assets by segment are not reported as the CODM does not regularly review asset information by segment.

Year Ended December 31
20252024
Home and Commercial ProductsHealthTotalHome and Commercial Products
Health (1)
Total
Revenue$599,503 $7,349 $606,852 $650,409 $4,284 $654,693 
Less:
Cost of sales448,913 1,786 450,699 483,444 1,042 484,486 
Selling, general and administrative expenses112,508 6,755 119,263 118,470 8,233 126,703 
Amortization of intangible assets200 111 311 200 102 302 
Segment profit (loss)$37,882 $(1,303)$36,579 $48,295 $(5,093)$43,202 
Reconciliation of segment profit (loss)
Interest expense, net703 613 
Pension termination expense— 7,611 
Other expense (income), net235 1,602 
Income before income taxes$35,641 $33,376 

(1) As noted in Note 15 - Acquisitions, the Company completed the acquisition of HealthBeacon on February 2, 2024. Therefore, the 2024 results for the Health segment represent activity from the date of acquisition through December 31, 2024.
v3.25.4
Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Revenue and Operating Profit (Loss)
The following table sets forth HealthBeacon’s revenue and operating profit (loss) for the years ended December 31:

 2025 2024
Revenue$7,349 $4,284 
Operating profit (loss)$(710)$(4,277)
Schedule of Final Value Assets Acquired and Liabilities Assumed
The following table presents the final value of assets acquired and liabilities assumed:
Fair Values as of
February 2, 2024
Cash and cash equivalents$147 
Current assets1,452 
Property, plant and equipment, net6,634 
Goodwill847 
Other intangible assets, net1,111 
Total assets acquired10,191 
Liabilities, current2,016 
Liabilities, non-current616 
Total liabilities acquired2,632 
Purchase Price$7,559 
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (U.S. Treasury Bills) (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
treasuryBill
Dec. 31, 2025
USD ($)
Basis Of Presentation And Policies [Line Items]      
Investments of excess cash on hand $ 9.8    
Number of U.S. treasury bills | treasuryBill   2  
Prepaid expenses and other current assets      
Basis Of Presentation And Policies [Line Items]      
Debt securities, held-to-maturity, amortized cost   $ 5.0 $ 0.0
Cash and Cash Equivalents      
Basis Of Presentation And Policies [Line Items]      
Debt securities, held-to-maturity, amortized cost   $ 0.0 $ 0.0
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Trade Receivables) (Details)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Five Largest Customers | Consolidated Net Accounts Receivable | Customer Concentration Risk    
Revenue, Major Customer [Line Items]    
Concentration risk (as a percent) 65.00% 68.00%
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Accounts Payable - Supplier Finance Program, Additional Information) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accounting Policies [Abstract]    
Limit on payment obligations $ 65,000  
Outstanding payment obligations, current $ 29,876 $ 56,940
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration] Accounts payable Accounts payable
Settlement of outstanding payment obligations $ 21,800 $ 48,200
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Supplier Finance Program) (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
Supplier Finance Program, Obligation [Roll Forward]  
Confirmed obligations outstanding as of January 1 $ 56,940
Invoices confirmed during the year 170,263
Confirmed invoices paid during the year (197,327)
Confirmed obligations outstanding as of December 31 $ 29,876
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Transfer of Financial Assets) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Accounts receivable derecognized $ 145.0 $ 149.7  
Loss on sale of accounts receivable $ 0.0 $ 0.0 $ 0.0
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Property, Plant and Equipment, Net) (Details)
Dec. 31, 2025
Buildings  
Property, Plant and Equipment [Line Items]  
Useful life (in years) 40 years
Machinery, Equipment, Furniture, and Fixtures | Minimum  
Property, Plant and Equipment [Line Items]  
Useful life (in years) 3 years
Machinery, Equipment, Furniture, and Fixtures | Maximum  
Property, Plant and Equipment [Line Items]  
Useful life (in years) 7 years
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Goodwill and Intangible Assets) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Goodwill and intangible asset impairment $ 0 $ 0 $ 0
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Product Development Costs) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]      
Product development costs $ 13.2 $ 13.7 $ 12.4
v3.25.4
Nature of Operations and Summary of Significant Accounting Policies (Stock Compensation) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Payment Arrangement, Nonemployee | Director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense   $ 179 $ 175  
Share-based Payment Arrangement, Nonemployee | Board of Directors Chairman        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense   $ 250 $ 250  
Performance Shares | Executive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Restriction period from retirement date, participant's death or permanent disability (in years) 3 years      
Number of shares issued during the period (in shares)   306,039 241,947 169,227
Number of shares available for grant (in shares)   705,355    
Share-based compensation expense   $ 2,800 $ 5,100 $ 4,200
Restricted Stock | Share-based Payment Arrangement, Nonemployee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares issued during the period (in shares)   71,999 60,235 100,238
Number of shares available for grant (in shares)   361,174    
Share-based compensation expense   $ 1,300 $ 1,200 $ 1,200
Election to receive common shares in lieu of cash, maximum percentage of annual retainer (as a percent)   100.00%    
Restricted Stock | Share-based Payment Arrangement, Nonemployee | Director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense   $ 112 110  
Restricted Stock | Share-based Payment Arrangement, Nonemployee | Board of Directors Chairman        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense   $ 150 $ 150  
Restricted Stock, Voluntary Elections | Share-based Payment Arrangement, Nonemployee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares issued during the period (in shares)   0 0 0
Restriction Period One | Performance Shares | Executive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Restriction period from award date (in years) 3 years      
Restriction Period One | Restricted Stock | Share-based Payment Arrangement, Nonemployee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Restriction period from award date (in years)   10 years    
Restriction Period Two | Performance Shares | Executive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Restriction period from award date (in years) 5 years      
Restriction Period Two | Restricted Stock | Share-based Payment Arrangement, Nonemployee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Restriction period from award date (in years)   5 years    
Restriction Period Three | Performance Shares | Executive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Restriction period from award date (in years) 10 years      
v3.25.4
Property, Plant and Equipment, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, at cost $ 71,870 $ 70,751  
Less allowances for depreciation and amortization 41,617 36,350  
Property, plant and equipment, net 30,253 34,401 $ 27,401
Depreciation 5,600 4,500 $ 4,200
Land      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, at cost 226 226  
Furniture and fixtures      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, at cost 10,146 9,946  
Building and improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, at cost 9,583 9,511  
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, at cost 33,523 33,021  
Internal-use capitalized software      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, at cost 16,696 15,867  
Construction in progress      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, at cost $ 1,696 $ 2,180  
v3.25.4
Goodwill and Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Feb. 02, 2024
Finite-Lived Intangible Assets, Net [Abstract]        
Gross Carrying Amount $ 4,524 $ 4,211    
Accumulated Amortization (2,431) (2,110)    
Net Balance 2,093 2,101    
Amortization of intangible assets 311 302 $ 200  
Expected Annual Amortization Expense of Intangible Assets for Next Five Years:        
2026 400      
2027 400      
2028 400      
2029 400      
2030 $ 400      
Intangible assets, weighted average amortization period (in years) 6 years 1 month 6 days      
Goodwill $ 7,099 7,099    
HealthBeacon        
Expected Annual Amortization Expense of Intangible Assets for Next Five Years:        
Goodwill       $ 847
Goodwill acquired   800    
Trademarks        
Finite-Lived Intangible Assets, Net [Abstract]        
Gross Carrying Amount 3,100 3,100    
Accumulated Amortization (2,208) (2,008)    
Net Balance 892 1,092    
Developed technology        
Finite-Lived Intangible Assets, Net [Abstract]        
Gross Carrying Amount 1,424 1,111    
Accumulated Amortization (223) (102)    
Net Balance $ 1,201 $ 1,009    
v3.25.4
Current and Long-Term Financing (Debt Schedule) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Line of Credit Facility [Line Items]    
Total outstanding borrowings $ 50,000 $ 50,000
Total available borrowings, net of limitations, under revolving credit agreements 123,783 107,257
Unused available borrowings $ 73,783 $ 57,257
Weighted average stated interest rate on total borrowings 5.94% 5.20%
Weighted average effective interest rate on total borrowings (including interest rate swap agreements) 3.30% 2.50%
Line of Credit | Revolving credit agreements    
Line of Credit Facility [Line Items]    
Total outstanding borrowings $ 50,000 $ 50,000
v3.25.4
Current and Long-Term Financing (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Line of Credit Facility [Line Items]      
Interest paid $ 0.9 $ 0.5 $ 3.0
Interest capitalized 0.0 $ 0.0 $ 0.0
Borrowing capacity 125.0    
Debt instrument, face amount $ 25.0    
Unused commitment fee (as a percent) 0.20%    
Line of Credit | SOFR      
Line of Credit Facility [Line Items]      
Basis spread on variable rate (as a percent) 1.65%    
Line of Credit | Base Rate      
Line of Credit Facility [Line Items]      
Basis spread on variable rate (as a percent) 0.00%    
v3.25.4
Derivative Financial Instruments (Narrative) (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Foreign currency exchange contracts    
Derivative [Line Items]    
Notional amount $ 1.7 $ 18.8
Fair value of foreign currency exchange contracts (0.1) 0.8
Interest rate swaps    
Derivative [Line Items]    
Notional amount 50.0 50.0
Interest rate swap agreements receivable $ 2.0 $ 4.0
v3.25.4
Derivative Financial Instruments (Interest Rate Derivatives) (Details) - Interest rate swaps - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Derivative [Line Items]    
Notional Amount $ 50.0 $ 50.0
Average Fixed Rate 1.60% 1.60%
v3.25.4
Derivative Financial Instruments (Fair Value of Derivative Instruments as Recorded in Consolidated Balance Sheets) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Asset Derivatives    
Total derivatives, asset derivatives $ 2,030 $ 4,741
Liability Derivatives    
Total derivatives, liability derivatives 126 0
Prepaid expenses and other current assets    
Asset Derivatives    
Interest rate swap agreements, asset derivatives 831 1,144
Foreign currency exchange contracts, asset derivatives 0 789
Other current liabilities    
Liability Derivatives    
Interest rate swap agreements, liability derivatives 0 0
Foreign currency exchange contracts, liability derivatives 126 0
Other non-current assets    
Asset Derivatives    
Interest rate swap agreements, asset derivatives 1,199 2,808
Other long-term liabilities    
Liability Derivatives    
Interest rate swap agreements, liability derivatives $ 0 $ 0
v3.25.4
Leasing Arrangements (Narrative) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Lessee, Lease, Description [Line Items]      
Impairment charges   $ 700  
Leasing $ 5,672 $ 3,220 $ 0
Minimum      
Lessee, Lease, Description [Line Items]      
Remaining lease terms (in years) 1 month    
Maximum      
Lessee, Lease, Description [Line Items]      
Remaining lease terms (in years) 12 years    
Extend lease terms (in years) 5 years    
v3.25.4
Leasing Arrangements (Lease Cost) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Leases [Abstract]    
Operating lease cost $ 7,172 $ 8,112
Finance lease cost    
Amortization of leased assets 74 72
Interest on lease liabilities 22 28
Finance lease cost 96 100
Variable lease cost 318,309 368,948
Short-term lease cost 46 52
Total lease cost $ 325,623 $ 377,212
v3.25.4
Leasing Arrangements (Supplemental Cash Flow and Non-cash Information) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Lessee Disclosure [Abstract]    
Cash paid for amounts included in the measurement of lease liabilities – operating cash flows from leases $ 8,066 $ 8,799
Right-of-use assets obtained in exchange for lease obligations of operating leases – non-cash activity 3,397 2,624
Right-of-use assets obtained in exchange for lease obligations of finance leases – non-cash activity $ 6 $ 73
v3.25.4
Leasing Arrangements (Undiscounted Future Lease Payments for Operating Leases) (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
Undiscounted Future Lease Payments  
2026 $ 7,530
2027 7,079
2028 6,661
2029 6,493
2030 5,791
Thereafter 16,889
Total lease payments 50,443
Less: impact of discounting 8,530
Present value of lease payments $ 41,913
v3.25.4
Leasing Arrangements (Weighted Average Remaining Lease Term and Discount Rate) (Details)
Dec. 31, 2025
Dec. 31, 2024
Lessee Disclosure [Abstract]    
Weighted average remaining lease term in years - operating leases 7 years 3 months 18 days 8 years 3 months 18 days
Weighted average remaining lease term in years - finance leases 2 years 7 months 6 days 3 years 7 months 6 days
Weighted average discount rate - operating leases 5.20% 5.10%
Weighted average discount rate - finance leases 7.30% 7.30%
v3.25.4
Stockholders' Equity and Earnings Per Share (Narrative) (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
series
vote
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Nov. 30, 2025
shares
Class of Stock [Line Items]        
Number of series of preferred stock | series 1      
Shares repurchased (in shares) | shares 506,925 668,785    
Shares repurchase price | $ $ 9,011 $ 14,189 $ 3,074  
Share repurchase price, net of excise tax | $ $ 9,000 $ 14,100    
2026 and 2027 Stock Repurchase Plan        
Class of Stock [Line Items]        
Shares repurchased (in shares) | shares 467,804 638,381 250,772  
Shares repurchase price | $ $ 8,300 $ 13,500 $ 3,100  
Incentive Plan        
Class of Stock [Line Items]        
Shares repurchased (in shares) | shares 39,121 30,404    
Shares repurchase price | $ $ 700 $ 600    
Class A Common Stock        
Class of Stock [Line Items]        
Number of votes per share | vote 1      
Approved repurchase amount (up to) | shares       25,000,000
Class B Common Stock        
Class of Stock [Line Items]        
Number of votes per share | vote 10      
v3.25.4
Stockholders' Equity and Earnings Per Share (Authorized Capital Stock) (Details)
shares in Thousands
 12 Months Ended
Mar. 05, 2025
shares
Feb. 21, 2025
shares
Dec. 31, 2025
$ / shares
shares
Dec. 31, 2024
$ / shares
shares
Class of Stock [Line Items]        
Preferred stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01
Preferred stock authorized (in shares)     5,000 5,000
Preferred stock outstanding (in shares)     0 0
Class A Common Stock        
Class of Stock [Line Items]        
Common stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01
Common stock authorized (in shares)     70,000 70,000
Common stock issued (in shares)     11,870 11,476
Treasury stock (in shares)     2,052 1,545
Class A common shares issued (in shares)     378 302
Number of shares surrendered to satisfy tax withholding obligation (in shares) 30 39    
Class B Common Stock        
Class of Stock [Line Items]        
Common stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01
Common stock, convertible conversion ratio     1 1
Common stock authorized (in shares)     30,000 30,000
Common stock issued (in shares)     3,587 3,603
Class B common converted to Class A common (in shares)     16 13
v3.25.4
Stockholders' Equity and Earnings Per Share (Changes in Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning balance $ 165,903 $ 147,267 $ 124,534
Other comprehensive income (loss) 2,002 (1,267) (1,596)
Reclassification adjustment to net income (loss) (1,034) 6,176 2,705
Tax effects 829 (2,819) 142
Ending balance 182,845 165,903 147,267
Accumulated Other Comprehensive Income (Loss)      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning balance (8,577) (10,667) (11,918)
Ending balance (6,780) (8,577) (10,667)
Foreign Currency      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning balance (12,279) (6,412) (8,924)
Other comprehensive income (loss) 3,914 (5,867) 2,792
Reclassification adjustment to net income (loss) 0 0 0
Tax effects 0 0 (280)
Ending balance (8,365) (12,279) (6,412)
Deferred Gain (Loss) on Cash Flow Hedging      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning balance 3,572 2,424 4,158
Other comprehensive income (loss) (2,191) 3,256 (4,529)
Reclassification adjustment to net income (loss) (1,204) (1,629) 2,231
Tax effects 919 (479) 564
Ending balance 1,096 3,572 2,424
Pension Plan Adjustment      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning balance 130 (6,679) (7,152)
Other comprehensive income (loss) 279 1,344 141
Reclassification adjustment to net income (loss) 170 7,805 474
Tax effects (90) (2,340) (142)
Ending balance $ 489 $ 130 $ (6,679)
v3.25.4
Stockholders' Equity and Earnings Per Share (Weighted Average Number of Shares Outstanding Reconciliation) (Details) - $ / shares
shares in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Equity [Abstract]      
Basic weighted average shares outstanding (in shares) 13,552 13,950 14,036
Dilutive effect of share-based compensation awards (in shares) 19 13 24
Diluted weighted average shares outstanding (in shares) 13,571 13,963 14,060
Basic earnings per share (in dollars per share) $ 1.95 $ 2.20 $ 1.80
Diluted earnings per share (in dollars per share) $ 1.95 $ 2.20 $ 1.80
v3.25.4
Revenue (Narrative) (Details)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue Benchmark | Customer Concentration Risk | Wal-Mart      
Disaggregation of Revenue [Line Items]      
Concentration risk (as a percent) 29.00% 29.00% 27.00%
Revenue Benchmark | Customer Concentration Risk | Amazon      
Disaggregation of Revenue [Line Items]      
Concentration risk (as a percent) 19.00% 24.00% 24.00%
Revenue Benchmark | Customer Concentration Risk | Five Largest Customers      
Disaggregation of Revenue [Line Items]      
Concentration risk (as a percent) 62.00% 65.00% 64.00%
Electric Appliances | Maximum      
Disaggregation of Revenue [Line Items]      
Warranty term (in years) 10 years    
Other products | Maximum      
Disaggregation of Revenue [Line Items]      
Warranty term (in years) 3 years    
Other products | Minimum      
Disaggregation of Revenue [Line Items]      
Warranty term (in years) 1 year    
Consumer Products | Maximum      
Disaggregation of Revenue [Line Items]      
Revenue contract duration (in years) 1 year    
Commercial Products | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | U.S.      
Disaggregation of Revenue [Line Items]      
Concentration risk (as a percent) 66.66%    
Commercial Products | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | Other      
Disaggregation of Revenue [Line Items]      
Concentration risk (as a percent) 33.33%    
Commercial Products | Maximum      
Disaggregation of Revenue [Line Items]      
Revenue contract duration (in years) 1 year    
v3.25.4
Revenue (Disaggregation of Revenue) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Leasing $ 5,672 $ 3,220 $ 0
Revenues, Total 606,852 654,693 625,625
Consumer products      
Disaggregation of Revenue [Line Items]      
Revenue 532,373 592,801 568,006
Commercial products      
Disaggregation of Revenue [Line Items]      
Revenue 59,898 51,755 52,327
Licensing      
Disaggregation of Revenue [Line Items]      
Revenue $ 8,909 $ 6,917 $ 5,292
v3.25.4
Contingencies (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
site
Dec. 31, 2024
USD ($)
Loss Contingencies [Line Items]    
Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration] Other current liabilities, Other long-term liabilities Other current liabilities, Other long-term liabilities
Accrual for environmental investigation and remediation activities $ 2.9 $ 3.9
Asset associated with reimbursement of costs $ 0.6  
Loss contingency, number of sites associated with cost reimbursement | site 2  
Minimum    
Loss Contingencies [Line Items]    
Estimate of additional expenses $ 0.0  
Maximum    
Loss Contingencies [Line Items]    
Estimate of additional expenses $ 1.0  
v3.25.4
Income Taxes (Income Before Income Taxes and Provision for Income Taxes) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income (loss) before income taxes      
Domestic $ 32,980 $ 33,403 $ 24,008
Foreign 2,661 (27) 7,688
Income before income taxes 35,641 33,376 31,696
Current income tax expense (benefit):      
Federal 2,555 8,457 3,412
State 1,142 2,790 1,452
Foreign 1,736 (1,361) 2,496
Total current 5,433 9,886 7,360
Deferred income tax expense (benefit):      
Federal 3,434 (4,573) 910
State 703 (998) (9)
Foreign (384) (1,698) (1,807)
Total deferred 3,753 (7,269) (906)
Income tax provision $ 9,186 $ 2,617 $ 6,454
v3.25.4
Income Taxes (Cash Paid for Income Taxes) (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
Income Tax Paid, by Individual Jurisdiction [Line Items]  
U.S. Federal $ 6,890
State 2,830
Foreign:  
Foreign Subtotal 3,655
Total cash paid for income taxes (net of refunds) 13,375
Canada  
Foreign:  
Foreign Subtotal 826
Mexico  
Foreign:  
Foreign Subtotal 2,612
Other  
Foreign:  
Foreign Subtotal $ 217
v3.25.4
Income Taxes (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Contingency [Line Items]      
Income tax refunds   $ 0.0 $ 0.1
Unrecognized tax benefits, permanent items $ 0.6 0.6 1.4
Unrecognized tax benefits, income tax penalties and interest income (expense) 0.0 0.0 0.0
Income tax examination, penalties and interest accrued $ 0.1 0.0 0.0
Federal      
Income Tax Contingency [Line Items]      
Income tax payments   5.8 3.1
Foreign and State      
Income Tax Contingency [Line Items]      
Income tax payments   $ 5.2 $ 3.2
v3.25.4
Income Taxes (Reconciliation of the Federal Statutory and Effective Income Tax Rate) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]        
Income (loss) before income taxes   $ 35,641 $ 33,376 $ 31,696
Amount        
Statutory taxes at 21%   7,485 7,009 6,656
State and local income taxes   1,602 1,610 1,224
Foreign tax effects   794 (4,330) (946)
Effect of cross-border tax laws   (702)    
Credits   (962) (1,148) (860)
Valuation allowances   166 635 13
Non-deductible expenses related to sec. 162(m)   812    
Other non-deductible expenses     1,196 402
Unrecognized tax benefits   (9) (32) 422
Accounting method change $ (2,300)   (2,278) 0
Other, net     (45) (457)
Income tax provision   $ 9,186 $ 2,617 $ 6,454
Percent        
Statutory taxes at 21%   21.00% 21.00% 21.00%
State and local income taxes   4.50% 4.80% 3.90%
Foreign statutory rate differences   2.20% (13.10%) (3.00%)
Effect of cross-border tax laws   (2.00%)    
Credits   (2.70%) (3.40%) (2.70%)
Valuation allowance   0.50% 1.90% 0.10%
Other     3.60% 1.30%
Non-deductible expenses related to sec. 162(m)   2.30%    
Unrecognized tax benefits   0.00% (0.10%) 1.30%
Accounting method change     (6.80%) 0.00%
Other     (0.10%) (1.50%)
Effective tax rate   25.77% 7.84% 20.36%
v3.25.4
Income Taxes (Summary of the Total Deferred Tax Assets and Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets    
Tax carryforwards $ 7,126 $ 5,982
Lease liabilities 1,797 2,003
Inventory 3,014 802
Accrued expenses and reserves 3,670 2,963
Other employee benefits 527 259
Depreciation and amortization 0 3,646
Other 0 32
Total deferred tax assets 16,134 15,687
Less: Valuation allowances (7,126) (5,982)
Deferred tax assets, net of valuation allowance 9,008 9,705
Deferred tax liabilities    
Accrued pension benefits 2,754 3,373
Depreciation and amortization 2,636 0
Other 11 0
Total deferred tax liabilities 5,401 3,373
Net deferred tax asset $ 3,607 $ 6,332
v3.25.4
Income Taxes (Summary of Operating Loss Carryforwards and Tax Credit Carryforwards) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Operating Loss Carryforwards [Line Items]    
Net deferred tax asset, Non-U.S. net operating loss $ 6,960  
Net deferred tax asset, Non-U.S. capital loss 166  
Tax carryforwards 7,126 $ 5,982
Valuation allowance 7,126  
Non-U.S. net operating loss    
Operating Loss Carryforwards [Line Items]    
Tax carryforwards   5,982
Valuation allowance 6,960 $ 5,982
U.S. capital loss    
Operating Loss Carryforwards [Line Items]    
Valuation allowance $ 166  
v3.25.4
Income Taxes (Gross Unrecognized Tax Benefits) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reconciliation of Unrecognized Tax Benefits [Roll Forward]      
Balance at beginning of period $ 618 $ 1,447 $ 256
Additions (reductions) based on tax positions related to prior years (39) (769)  
Additions based on tax positions related to prior years     769
Additions (reductions) based on tax positions related to the current year 0 0 493
Reductions for lapse of statute of limitations 0 (60) (71)
Reductions due to settlements with taxing authorities 0 0 0
Balance at end of period $ 579 $ 618 $ 1,447
v3.25.4
Retirement Benefit Plans (Narrative) (Details)
$ in Thousands
 3 Months Ended 4 Months Ended 8 Months Ended 12 Months Ended
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Aug. 31, 2024
Dec. 31, 2025
USD ($)
plan
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Retirement Benefits [Abstract]            
Number of active plans | plan       1    
Number of terminated plans | plan       1    
Defined benefit plan, funded (unfunded) status of plan   $ 13,400     $ 13,400  
Transfer to qualified replacement plan $ (13,400)          
Employee retirement benefits       $ 4,300    
Prepaid expenses and other current assets       3,700    
Other non-current assets       5,500    
Reclassification related to pension termination activity into earnings, before tax         7,600  
Reclassification related to pension termination activity into earnings, post-tax       48 5,668 $ 0
Discount rate for net periodic benefit (income) expense   0.00% 5.01%      
Expected long-term rate of return on assets for net periodic pension (income) expense   0.00% 3.00%      
Defined contribution plan, total costs       $ 7,400 $ 6,100 $ 5,000
v3.25.4
Retirement Benefit Plans (Assumptions Used in Accounting for Defined Benefit Plans) (Details)
 4 Months Ended 8 Months Ended 12 Months Ended
Dec. 31, 2024
Aug. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]          
Discount rate for net periodic benefit (income) expense 0.00% 5.01%      
Expected long-term rate of return on assets for net periodic pension (income) expense 0.00% 3.00%      
U.S. Pension Plan          
Defined Benefit Plan Disclosure [Line Items]          
Discount rate for pension benefit obligation         5.01%
Discount rate for net periodic benefit (income) expense         5.34%
Expected long-term rate of return on assets for net periodic pension (income) expense         4.00%
Canada Pension Plan          
Defined Benefit Plan Disclosure [Line Items]          
Discount rate for pension benefit obligation 4.58%   4.67% 4.58% 4.63%
Discount rate for net periodic benefit (income) expense     4.58% 4.63% 5.15%
Expected long-term rate of return on assets for net periodic pension (income) expense     6.00% 6.00% 6.00%
v3.25.4
Retirement Benefit Plans (Net Periodic Pension Expense) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]      
Settlement loss $ 0 $ 7,611 $ 0
U.S. Pension Plan      
Defined Benefit Plan Disclosure [Line Items]      
Interest cost 0 379 674
Expected return on plan assets   (521) (1,082)
Amortization of actuarial loss (gain)   238 358
Settlement loss   7,611 0
Net periodic pension (income) expense   7,707 (50)
Canada Pension Plan      
Defined Benefit Plan Disclosure [Line Items]      
Interest cost 140 147 162
Expected return on plan assets (271) (263) (258)
Amortization of actuarial loss (gain) 108 (44) 118
Net periodic pension (income) expense $ (23) $ (160) $ 22
v3.25.4
Retirement Benefit Plans (Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Loss (Income) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
U.S. Pension Plan      
Defined Benefit Plan Disclosure [Line Items]      
Current year actuarial loss (gain)   $ (998) $ (33)
Settlement loss   (7,611) 0
Amortization of actuarial (loss) gain   (238) (358)
Total recognized in other comprehensive loss (income)   (8,847) (391)
Canada Pension Plan      
Defined Benefit Plan Disclosure [Line Items]      
Current year actuarial loss (gain) $ (279) (346) (108)
Amortization of actuarial (loss) gain (108) 44 (118)
Total recognized in other comprehensive loss (income) $ (387) $ (302) $ (226)
v3.25.4
Retirement Benefit Plans (Obligation and Funded Status) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Change in plan assets        
Benefits paid   $ (4,300)    
Transfer to qualified replacement plan $ (13,400)      
Funded status at end of year     $ 13,400  
Amounts recognized in the balance sheets consist of:        
Deferred costs   5,500    
U.S. Pension Plan        
Change in benefit obligation        
Projected benefit obligation at beginning of year 104 104 12,916  
Interest cost   0 379 $ 674
Annuity purchase refund   0 441  
Actuarial (gain) loss   0 (1,610)  
Benefits paid   0 (1,030)  
Settlements   (104) (10,992)  
Foreign currency exchange rate changes   0 0  
Projected benefit obligation at end of year   0 104 12,916
Accumulated benefit obligation at end of year   0 104  
Change in plan assets        
Fair value of plan assets at beginning of year 13,485 13,485 25,156  
Actual return on plan assets   0 (90)  
Benefits paid   0 (1,030)  
Annuity purchase refund   0 441  
Settlements   0 (10,992)  
Other   0 0  
Foreign currency exchange rate changes   0 0  
Transfer to qualified replacement plan (13,400) (13,485) 0  
Fair value of plan assets at end of year   0 13,485 25,156
Funded status at end of year   0 13,381  
Amounts recognized in the balance sheets consist of:        
Deferred costs   0 13,381  
Components of accumulated other comprehensive loss consist of:        
Actuarial loss   0 (62)  
Deferred taxes   0 16  
Accumulated other comprehensive (loss) income   0 (46)  
Canada Pension Plan        
Change in benefit obligation        
Projected benefit obligation at beginning of year 3,077 3,077 3,401  
Interest cost   140 147 162
Annuity purchase refund   0 0  
Actuarial (gain) loss   (79) 18  
Benefits paid   (215) (217)  
Settlements   0 0  
Foreign currency exchange rate changes   149 (272)  
Projected benefit obligation at end of year   3,072 3,077 3,401
Accumulated benefit obligation at end of year   3,072 3,077  
Change in plan assets        
Fair value of plan assets at beginning of year $ 4,505 4,505 4,654  
Actual return on plan assets   466 645  
Benefits paid   (215) (217)  
Annuity purchase refund   0 0  
Settlements   0 0  
Other   (172) (189)  
Foreign currency exchange rate changes   226 (388)  
Transfer to qualified replacement plan   0 0  
Fair value of plan assets at end of year   4,810 4,505 $ 4,654
Funded status at end of year   1,738 1,428  
Amounts recognized in the balance sheets consist of:        
Deferred costs   1,738 1,428  
Components of accumulated other comprehensive loss consist of:        
Actuarial loss   592 205  
Deferred taxes   (103) (29)  
Accumulated other comprehensive (loss) income   $ 489 $ 176  
v3.25.4
Retirement Benefit Plans (Expected Benefit Payments) (Details) - Canada Pension Plan
$ in Thousands
Dec. 31, 2025
USD ($)
Defined Benefit Plan Disclosure [Line Items]  
2026 $ 241
2027 250
2028 247
2029 243
2030 236
2031-2035 1,114
Total $ 2,331
v3.25.4
Retirement Benefit Plans (Actual and Target Allocation Percentage for Pension Plan Assets) (Details) - Canada Pension Plan
Dec. 31, 2025
Dec. 31, 2024
Canadian equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Actual allocation 36.30% 32.70%
Canadian equity securities | Minimum    
Defined Benefit Plan Disclosure [Line Items]    
Target allocation 25.00%  
Canadian equity securities | Maximum    
Defined Benefit Plan Disclosure [Line Items]    
Target allocation 35.00%  
Non-Canadian equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Actual allocation 41.00% 37.70%
Non-Canadian equity securities | Minimum    
Defined Benefit Plan Disclosure [Line Items]    
Target allocation 25.00%  
Non-Canadian equity securities | Maximum    
Defined Benefit Plan Disclosure [Line Items]    
Target allocation 35.00%  
Fixed income securities    
Defined Benefit Plan Disclosure [Line Items]    
Actual allocation 22.70% 29.60%
Fixed income securities | Minimum    
Defined Benefit Plan Disclosure [Line Items]    
Target allocation 30.00%  
Fixed income securities | Maximum    
Defined Benefit Plan Disclosure [Line Items]    
Target allocation 50.00%  
v3.25.4
Retirement Benefit Plans (Fair Value Hierarchy) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
U.S.      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets $ 0 $ 13,485 $ 25,156
U.S. | Money Market Funds      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets   13,000  
Canada Pension Plan      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 4,810 4,505 $ 4,654
Canada Pension Plan | U.S. equity securities      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1,683 1,458  
Canada Pension Plan | Non-U.S. equity securities      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2,033 1,714  
Canada Pension Plan | Fixed income securities      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets $ 1,094 $ 1,333  
v3.25.4
Data by Geographic Region (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from unaffiliated customers $ 606,852 $ 654,693 $ 625,625
Property, plant and equipment, net 30,253 34,401 27,401
U.S.      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from unaffiliated customers 458,847 511,248 493,711
Property, plant and equipment, net 23,560 26,730 23,068
Other      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenue from unaffiliated customers 148,005 143,445 131,914
Property, plant and equipment, net $ 6,693 $ 7,671 $ 4,333
Other | Property, Plant and Equipment | Geographic Concentration Risk      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Concentration risk (or more) (as a percent) 10.00%    
v3.25.4
Segment Reporting - Narrative (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
segment
Segment Reporting [Abstract]      
Number of operating segments | segment 2   1
Number of reportable segments | segment 2   1
Concentration Risk [Line Items]      
Revenues $ 606,852 $ 654,693 $ 625,625
Home and Commercial Products | Customer One      
Concentration Risk [Line Items]      
Revenues 178,300 189,300  
Home and Commercial Products | Customer Two      
Concentration Risk [Line Items]      
Revenues 117,700 154,100  
U.S.      
Concentration Risk [Line Items]      
Revenues 458,847 511,248 493,711
Other      
Concentration Risk [Line Items]      
Revenues $ 148,005 $ 143,445 $ 131,914
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | U.S. | Commercial products      
Concentration Risk [Line Items]      
Concentration risk (as a percent) 66.66%    
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | Other | Commercial products      
Concentration Risk [Line Items]      
Concentration risk (as a percent) 33.33%    
v3.25.4
Segment Reporting - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Revenue $ 606,852 $ 654,693 $ 625,625
Less:      
Cost of sales 450,699 484,486 481,949
Selling, general and administrative expenses 119,263 126,703 108,395
Amortization of intangible assets 311 302 200
Operating profit 36,579 43,202 35,081
Reconciliation of segment profit (loss)      
Interest expense, net 703 613 3,000
Pension termination expense 0 7,611 0
Other expense (income), net 235 1,602 385
Income before income taxes 35,641 33,376 $ 31,696
Operating Segments      
Segment Reporting Information [Line Items]      
Revenue 606,852 654,693  
Less:      
Cost of sales 450,699 484,486  
Selling, general and administrative expenses 119,263 126,703  
Amortization of intangible assets 311 302  
Operating profit 36,579 43,202  
Operating Segments | Home and Commercial Products      
Segment Reporting Information [Line Items]      
Revenue 599,503 650,409  
Less:      
Cost of sales 448,913 483,444  
Selling, general and administrative expenses 112,508 118,470  
Amortization of intangible assets 200 200  
Operating profit 37,882 48,295  
Operating Segments | Health      
Segment Reporting Information [Line Items]      
Revenue 7,349 4,284  
Less:      
Cost of sales 1,786 1,042  
Selling, general and administrative expenses 6,755 8,233  
Amortization of intangible assets 111 102  
Operating profit (1,303) (5,093)  
Reconciling Items      
Reconciliation of segment profit (loss)      
Interest expense, net 703 613  
Pension termination expense 0 7,611  
Other expense (income), net $ 235 $ 1,602  
v3.25.4
Acquisitions - Narrative (Details) - HealthBeacon
€ in Millions, $ in Millions
 12 Months Ended
Feb. 02, 2024
EUR (€)
Feb. 02, 2024
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Asset Acquisition [Line Items]        
Business combination, consideration transferred € 6.9 $ 7.5    
Transaction costs     $ 0.0 $ 1.3
v3.25.4
Acquisitions - Schedule of Revenue And Operating Profit (Loss) (Details) - HealthBeacon - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Asset Acquisition [Line Items]    
Revenue $ 7,349 $ 4,284
Operating profit (loss) $ (710) $ (4,277)
v3.25.4
Acquisitions - Schedule of Final Value Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Feb. 02, 2024
Asset Acquisition [Line Items]      
Goodwill $ 7,099 $ 7,099  
HealthBeacon      
Asset Acquisition [Line Items]      
Cash and cash equivalents     $ 147
Current assets     1,452
Property, plant and equipment, net     6,634
Goodwill     847
Other intangible assets, net     1,111
Total assets acquired     10,191
Liabilities, current     2,016
Liabilities, non-current     616
Total liabilities acquired     2,632
Purchase Price     $ 7,559
v3.25.4
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Allowance for credit losses      
Valuation allowances and reserves [Roll Forward]      
Balance at Beginning of Period $ 2,521 $ 1,036 $ 957
Charged to Costs and Expenses 184 1,485 79
Charged to Other Accounts 0 0 0
Deductions (1,022) 0 0
Balance at End of Period 1,683 2,521 1,036
Deferred tax valuation allowances      
Valuation allowances and reserves [Roll Forward]      
Balance at Beginning of Period 5,982 2,780 2,153
Charged to Costs and Expenses 338 686 6
Charged to Other Accounts 0 5,367 0
Deductions 806 (2,851) (621)
Balance at End of Period $ 7,126 $ 5,982 $ 2,780